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Chapter 1:  INTRODUCTION 
 
Uterine gland morphogenesis and growth is a postnatal event in pigs [Hadek and 
Getty, 1959; Bal and Getty, 1970; Spencer et al., 1993a], sheep [Wiley et al., 1986; 
Bartol et al., 1988a; 1988b], and rodents [Branham et al., 1985].  The impact that uterine 
glands have throughout pregnancy is mediated through synthesis and secretion of a 
complex assortment of proteins collectively known as histotroph [Roberts and Bazer, 
1988].  Porcine uterine histotroph aids in regulation of conceptus survival and 
development [Bazer, 1975], initiation of steroidogenesis for production of estrogen 
needed for maternal recognition of pregnancy, early placentation, and conceptus 
survival [Bazer, 1975; Roberts and Bazer, 1988].  Composition of histotroph in various 
farm species is dependent upon stage of estrous cycle or pregnancy [Roberts and 
Bazer, 1988] and includes growth factors, hormones, transport proteins, and other 
progesterone-induced proteins [Trout et al., 1992; Spencer et al., 1999].  
Uterine secretions are critical for conceptus survival, particularly in species where 
there is an extended period prior to trophoblast attachment and placentation.  The 
impact that histotroph has on conceptus survival is apparent from studies in ewes in 
which uterine gland development can be inhibited perinatally by endocrine disruption, 
which alters subsequent adult uterine structure [Gray et al., 2001c] and function [Bartol 
et al., 1993; Tarleton et al., 2003]. 
The porcine uterus is not completely differentiated at birth; with 
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differentiation being initiated prenatally and completed postnatally [Hadek and Getty, 
1959; Bal and Getty, 1970; Spencer et al., 1993a; Tarleton et al., 2001].  Uterine gland 
morphogenesis (adenogenesis) begins at birth and rapidly develops to functional 
maturity by 120 days.  The histological morphology of the porcine neonatal uterus begins 
with the differentiation of glandular epithelium (GE) from the luminal epithelium (LE), 
which is followed by proliferation, tubular coiling, and branching of the GE deep into the 
uterine stroma [Spencer et al., 1993a].  
The mechanisms involved with uterine adenogenesis are regulated locally, 
independent of the ovary [Wu and Dziuk, 1988; Spencer et al., 1993a]. Uterine 
adenogenesis occurs through changes in cell proliferation and movement, cell-to-cell 
interaction, alterations in extracellular matrix (ECM), and many paracrine pathways 
[Bartol et al., 1993; Gray et al., 2001b].  Epithelial differentiation is regulated by stromal 
growth factors (and their respective receptors) such as fibroblast growth factor (FGF)-7, 
FGF-10, hepatocyte growth factor (HGF), transforming growth factor-β (TGF-β), and 
insulin like growth factor (IGF)-I and II are key for gland differentiation and proliferation 
[Taylor et al., 2001; Gray et al., 2001b]. 
The regulation of adult porcine uterine gland function is dependent upon 
conceptus secretion of estrogen in early pregnancy to signal maternal recognition of 
pregnancy [Geisert et al., 1982c].  Conceptus secretion of estrogens induce 
sequestering of PGF2α in the uterine lumen to prevent luteolysis.  As a result, corpora 
lutea (CL) are maintained and continue to secrete progesterone needed for maintenance 
of pregnancy to term [Bazer et al., 1984; Geisert et al., 1994].  Increasing plasma 
content of progesterone stimulates uterine protein secretions which increase during the 
luteal phase of the estrous cycle and early pregnancy.  Several progesterone-induced 
proteins such as uteroferrin [Bazer and Roberts, 1983; Bazer et al., 1984], retinol binding 
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protein (RBP) [Clawitter et al., 1990], lysozyme [Roberts et al., 1993], plasmin/trypsin 
inhibitor (PI) [Roberts et al., 1993], and IGF-I [Simmen and Simmen, 1990] have been 
isolated in the uterus during pregnancy and are considered to be important factors for 
conceptus survival. 
Specific changes in gene expression involved in the completion of uterine gland 
development during the first 56 days of postnatal growth in the pig have not been well 
described or understood.  Therefore, the objective of this study was to identify 
differentially expressed genes involved in uterine gland development in the neonatal pig 
uterus using suppression subtractive hybridization (SSH).  Characterization of the gene 
expression profile for early postnatal uterine development in the pig will help determine 
biological significance and aid in strategies for improved reproductive potential. 
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Chapter 2:  LITERATURE REVIEW 
 
2.1 Uterine Gland Morphogenesis in Rodents and Domestic 
Farm Animals 
Morphogenesis of tissues occurs as groups of cells undergo organized changes 
in cellular events which lead to a change in the tissue form and function [Bernfield, 
1981].  Uterine morphogenesis begins during embryonic development of the 
paramesonephric or Müllerian ducts [Marion and Gier, 1971].  Initial uterine 
morphogenesis begins with the organization of the two functional compartments of the 
uterus, the endometrium and myometrium [Bartol et al., 1993].  Histogenesis of the 
endometrium involves stratification of undifferentiated mesenchyme into either a dense 
stromal zone (stratum compactum) characteristic of the luminal epithelium (LE) or 
loosely organized stromal zone (stratum spongiosum) for which the characteristic 
glandular epithelium (GE) will differentiate and invade.  Myometrial differentiation is also 
initiated forming the inner circular and the outer longitudinal smooth muscle layers of the 
mature uterus [Bartol et al., 1993; Gray et al., 2001b].  After development of the inner 
mucosal endometrium and inner and outer smooth muscle myometrium, there is a 
coordinated development of the histoarchitecture of the uterus [Bartol et al., 1993], which 
is species specific, as illustrated in Figure 2.1. 
Uterine morphogenesis in sheep, cattle, mice, and pigs occurs in a progressive 
manner, initiated prenatally and completed postnatally, at some point before puberty. 
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Figure 2.1.  Histoarchitecture of the porcine uterus.  The mature pig 
uterus is composed of two functional compartments, the endometrium 
and myometrium and each compartment is subdivided.  The innermost 
layer at the lumen is the luminal epithelium that lines the uterus.  The 
glandular epithelium penetrates deep into the endometrium and functions 
to secrete proteins into the uterine lumen in early pregnancy.  The 
myometrium is composed of the inner circular and outer longitudinal 
layers. 
 
While the type of placentation and length of gestation differ between species, the pattern 
of uterine differentiation was similar [Wiley et al., 1986].  Although similar, postnatal 
uterine gland development in livestock species includes uterine gland coiling and 
branching, whereas there is no tight coiling or branching of the uterine glands in rodents 
[Mossman, 1987]. 
Sheep and Cattle 
A morphological difference in the endometrium of ruminants compared to other 
species is the presence of multiple aglandular caruncules.  Caruncles are LE-covered 
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dense stroma sites for synepitheliochorial placentation and nutrient exchange whereas 
the intercaruncular areas have abundant uterine glands [King et al., 1980; 1981]. 
Uterine morphogenesis in ruminants, such as cattle and sheep, begins when the 
embryonic paramesonephric duct fuses leading to the formation of a bicornuate uterus, 
and is attained between Days 34 and 55 of gestation in sheep [Wiley et al., 1986],.  
Distinct raised luminal clefts are apparent which later develop into caruncles by Day 90 
of gestation in sheep [Wiley et al., 1986]. The stratum compactum and stratum 
spongiosum are visible, and the inner circular and outer circular layers appear to be 
differentiating at this time.  Between gestational Days 135 and 150 in sheep [Wiley et al., 
1986] and at Day 250 in cattle [Marion and Gier, 1971; Atkinson et al., 1984], uterine 
gland morphogenesis is initiated, as seen by the presence of shallow depressions in the 
LE.  In the ewe, adenogenesis is initiated at the time of birth when progesterone is 
removed from the fetal environment [Gray et al., 2000b]. 
At postnatal day (PND) 0, or birth, shallow epithelial depressions are visible in 
sheep at the presumptive intercaruncular (glandular) sites.  Epithelial buds proliferate 
and begin to invade through the uterine stroma between PND 7 and 14.  Wiley and 
coworkers [1986] noted the presence of tubular glands at PND 9.  By PND 21, these 
tubes begin to coil and branch, continuing branching morphogenesis after PND 21 so 
that glands extend to the myometrium by PND 26 [Wiley et al., 1986; Gray et al., 2001b].  
Although the uterine endometrium is histoarchitecturally similar to the adult by PND 56, 
complete uterine maturation may not be accomplished until puberty or establishment of 
pregnancy [Kennedy et al., 1974]. 
In sheep, endometrial gland differentiation can be inhibited by neonatal exposure 
to progestins, creating a uterine gland knockout (UGKO) phenotype [Bartol et al., 
1988b].  Disruption of normal glandular developmental patterns with exogenous 
progestin is specific to adenogenesis, as development of the myometrium and other 
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uterine structures are not affected [Gray et al., 2000b; 2001a; 2002].  Uterine glands of 
UGKO ewes do not penetrate the intercaruncular stroma, neither is there an identifiable 
stratum compactum, as in the normal phenotype [Gray et al., 2001a].  Therefore, UGKO 
ewes offer an insight to the mechanisms involved in neonatal adenogenesis.  Gray and 
coworkers [2000a] administered norgestomet (a synthetic progestin) for 8, 16, or 32 
weeks to neonatal ewes and found that exposure for as short as 8 weeks was sufficient 
to inhibit uterine gland development.   
Fertility is negatively affected in UGKO ewes, as there is a failure to establish 
pregnancy due to conceptus death during the peri-implantation period [Gray et al., 
2002].  Endocrine disruption of early postnatal gland development influences uterine 
secretions by altering the morphological glandular composition of the uterine 
intercaruncular area.  As a result of the lack of uterine glandular development in the 
neonatal uterus, histotroph is not adequately synthesized or secreted.  Gray and 
coworkers [2001c] demonstrated the presence of healthy conceptuses in UGKO ewes 
on Days 6 and 9 of pregnancy, but no conceptuses or only tubular, nonelongated 
conceptuses were present on Day 14.  
Uterine protein secretions that are involved in mediating the ovine maternal-
conceptus interaction are altered in the UGKO phenotype.  Many of the uterine secreted 
factors are critical to conceptus survival during implantation, including mucin 1 (Muc-1), 
glycosylation-dependent cell adhesion molecule 1 (GlyCAM-1), and osteopontin (OPN).  
Mucin 1 (Muc-1) inhibits cell-cell and cell-ECM interactions [Komatsu et al., 1997] and is 
presumably involved in regulation of conceptus trophectoderm adhesion to maternal LE 
[DeSouza et al., 2000].  Johnson and coworkers [2001] showed Muc-1 to be localized to 
the apical surface of the LE and GE.  Glandular epithelium muc-1 expression was high 
throughout the estrous cycle and early pregnancy, while LE expression decreased.  
Expression of Muc-1 in UGKO ewes was not different from normal ewes [Gray et al., 
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2002].  The role that the secreted protein osteopontin serves during early pregnancy 
may be as an adhesion molecule during conceptus attachment [Johnson et al., 1999a; 
1999b].  In pregnancy, OPN has been shown to be restricted to the endometrial glands 
of Day 13 to 19 pregnant ewes [Johnson et al., 1999a].  Immunological detection of OPN 
showed the protein to be present on the luminal and glandular epithelial cells of the 
uterus [Johnson et al., 1999b], but was undetectable in UGKO ewes [Gray et al., 2002].  
Interferon τ (IFNτ) is the ovine maternal recognition of pregnancy signal [Bazer et al., 
1997] that is secreted during conceptus elongation.  This critical developmental factor 
was shown to be absent in flushings from UGKO ewes whether conceptus was absent, 
degenerated tubular conceptus, or fragmented filamentous conceptus [Gray et al., 
2002].  In the absence of uterine glands, conceptus development is defective and 
pregnancy cannot be maintained.  These results indicate secretions from the uterine 
glands are essential for conceptus development and attachment to the uterine surface.  
Rodents 
On gestational Day 15-16, the embryonic paramesonephric duct partially fuses in 
rats and mice to form a bicornuate uterus [Mossmann, 1987].  At birth, about 4 days 
after paramesonephric duct fusion, the uterus of female mice and rats are still devoid of 
endometrial glands.  The endometrium consists of a simple epithelium maintained on an 
undifferentiated mesenchyme.  The GE begins to bud by PND 5, creating epithelial 
invaginations.  Simple, tubular glands are not apparent until PND 7 in mice and PND 9 in 
rats.  In rats, these events correlate with elevated serum estradiol levels and increased 
uterine sensitivity to estradiol [Branham et al., 1985]. 
Rodent endometrial gland differentiation is inhibited by exposure with the 
antiestrogen tamoxifen [Branham et al., 1985].  Responses to tamoxifen are dependent 
upon the dose and period of exposure, resulting in either an agonist or antagonist 
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response.  For example, neonatal rats treated with tamoxifen initiated early myometrial 
differentiation, but delayed the emergence of endometrial glands [Branham et al., 1985].  
2.2 Developmental Biology of Porcine Uterine Gland 
Morphogenesis 
During porcine conceptus development, the paramesonephric ducts fuse at the 
caudal ends, resulting in the formation of a short uterine body and extensive uterine 
horns [Mossman, 1989].  Postnatal development of pig uterine glands begins at birth and 
rapidly reaches functional maturity by PND 120 [Hadek and Getty, 1959].  
Morphogenesis of functional uterine glands is necessary for normal uterine function and 
conceptus survival.  The histological conformation of the porcine uterus during early 
postnatal development has been characterized in detail including the anatomical 
changes throughout the differentiation and budding of GE from the LE followed by 
proliferation, tubular coiling, and branching into the uterine stroma [Hadek and Getty, 
1959; Bal and Getty, 1970; Bartol et al., 1993; Spencer et al., 1993a; Tarleton et al., 
1998]. 
Postnatal uterine gland development has been shown to be related to age of the 
animal [Hadek and Getty, 1959].  At the time of birth, or PND 0, the uterine wall is 
undifferentiated [Bal and Getty, 1970] with only shallow epithelial depressions [Hadek 
and Getty, 1959] (Figure 2.2 A), which are believed to be the predecessor for the uterine 
glands of the adult pig uterus [Hadek and Getty, 1959; Bartol et al., 1993].  There is no 
distinct outer longitudinal layer of myometrium, but an inner circular layer is present [Bal 
and Getty, 1970].  At this time, the thickness of the uterine wall is increasing and the 
weight of the endometrium is about 55% of the total uterine wall thickness [Hadek and 
Getty, 1959]. 
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By PND 7, the uterine glands appear as coiled tubular glands in the shallow 
stratum compactum while the stratum spongiosum is becoming thicker and many tubular 
glands can be observed by PND 14 (Figure 2.2 B) [Spencer et al., 1993a; 1993b].  The 
glands are described as having “large, funnel-like openings” [Hadek and Getty, 1959] 
and coil throughout the top one-third of the endometrium [Spencer et al., 1993a]. 
Distinct tubular glands have begun to branch throughout the endometrium by 
PND 28 and GE can be observed within the uterine stroma (Figure 2.2 C).  Furthermore, 
uterine mucosal folds begin to develop and increase the uterine surface area [Hadek 
and Getty, 1959; Bal and Getty, 1970].  
By PND 56, uterine glands are dense and extensive.  At this time, the glands are 
coiled, branched, and extend from the luminal surface to the myometrium (Figure 2.2 E).  
In addition, the endometrial folds and the inner circular and outer longitudinal 
myometrium are well-developed [Spencer et al., 1993a; Bartol et al., 1993].  Growth of 
the uterus and its functional compartments continue to grow in a prolific manner while 
the endometrial folds continue to grow in a more unpredictable manner [Hadek and 
Getty, 1959] until the uterus reaches functional maturity by PND 120 [Hadek and Getty, 
1959; Bal and Getty, 1970]. 
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Figure 2.2.  Histological view of the changing morphology of the 
developing neonate pig uterus.  Panel A) PND 0: Shallow epithelial 
depressions (black arrow) can be observed.  B) PND 14: Tubular glands 
begin to coil and branch (black arrow).  C) PND 28: Continued glandular 
branching morphogenesis.  D) PND 42: Branching morphogenesis 
continues.  E) PND 56: Glands are now dense and extensive throughout 
the endometrium.  F) PND 42 with abnormal uterine gland development. 
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Note the absence of glands, thick endometrium, and thick myometrium 
(brace).  All images were taken at 10 x. 
2.3 Regulation of Porcine Uterine Gland Morphogenesis 
Tissue morphogenesis is a result of the synchronization of cellular activities that 
include cell adhesion, proliferation, apoptosis, and changes in cell shape, ultimately 
initiating cell movement [Bernfield, 1981].  Based on the regulatory pathways for gland 
development in other epitheliomesenchymal organs, porcine uterine gland 
morphogenesis is likely to be regulated locally [Spencer et al., 1993a] by several factors 
including changes in: 
• Cell proliferation and movement  
• Paracrine cell-to-cell and cell-to-extracellular matrix interactions [Bartol et 
al., 1993; Gray et al., 2001b] 
• Secretion of many biochemical factors [for review see Gray et al., 2001b] 
Changes in cell proliferation and movement 
 
Spencer and coworkers [1993a] indicated that the increased synthesis of DNA in 
epithelial cells, with steady decrease in the stromal cells, is indicative of the emergence 
of uterine glands via budding of the GE from LE in the neonate pig, rather than a result 
of cell proliferation.  Furthermore, histochemical studies at the stromal-epithelial 
boundary provide evidence that bud outgrowth and invagination does not require 
localized cell proliferation [Spencer et al., 1993a]. 
Epithelial DNA synthesis during uterine adenogenesis is regulated sequentially 
and locally in a tissue microenvironment [Bartol et al., 1988b; Spencer et al., 1993a; 
Gray et al., 2001b], likely a result of epithelial-mesenchymal interactions.  The conditions 
of this local microenvironment are vital for the proliferation of glands [Bartol et al., 1988a] 
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which is possibly an effect of the stroma to allow a localized response to hormones 
[Cunha and Lung, 1979].  
Changes in cell-to-cell interactions 
Sharpe and Ferguson [1988] stated that epithelial-mesenchymal interactions lead 
to an alteration of either or both tissues that would not have taken place had the 
interaction not occurred.  This type of interaction is known to support and regulate the 
morphogenesis of many organs [Bernfield, 1981], including the uterus [Gray et al., 
2001b] by locally controlling cell movement, adhesion, differentiation, and proliferation 
[Sharpe and Ferguson, 1988; Taylor et al., 2001; Gray et al., 2001b]. 
Cunha and Lung [1979] demonstrated in the mouse that uterine stroma directs 
morphogenesis of the uterine epithelium as bladder epithelium could be transformed to 
uterine epithelium if placed over uterine stroma.  Additional rodent tissue recombination 
studies suggest in the developing neonate uterus that the mesenchyme dictates the 
epithelial developmental pattern while presence of the epithelium allows for the 
organization of uterine stroma and differentiation of myometrium [Cunha, 1976; Cunha et 
al., 1983]. 
Developmental epithelial-mesenchymal interactions tend to be reciprocal in 
relation to time.  For the most part, the epithelium will signal to the mesenchyme, which 
subsequently signals back to the epithelium.  This signaling occurs in such a way to 
allow for organized regulation of cell proliferation, differentiation, and morphogenesis 
[Sharpe and Ferguson, 1988].  
When the epithelial-mesenchymal interaction is disrupted, normal 
morphogenesis is unable to take place.  For example, UGKO ewes treated with a 
progestin implant for 32 weeks after birth lack the ability to develop uterine glands [Gray 
et al., 2000a].  The UGKO ewes exhibit a simple LE over a dense stroma, but appeared 
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to have normal myometrial development.  It is likely that this prepubertal exposure to 
progestin interrupts the normal epithelial-mesenchymal interaction to prevent proper 
development of the uterus [Spencer et al., 1999; Taylor et al., 2001]. 
Changes in cell-to-extracellular matrix interactions 
The ECM functions as a supportive framework that serves to facilitate individual 
cells to function as a unit.  It is comprised of fibrous proteins, glycosaminoglycans 
(GAG’s), glycoproteins, and interstitial fluid [Bernfield, 1981].  Included in the GAGs are 
hyalauronic acid (HA), sulfated GAGs (SGAGs), chondroitin sulfate (CS), heparan 
sulfate (HS), and keratan sulfate [Bartol et al., 1993]. 
Interactions of the ECM during uterine adenogenesis, as in other tissue 
morphogenesis, involve the presence of collagens for structural organization, GAG 
concentration to dictate matrix association (loose, soft, firm, or rigid), and glycoproteins 
such as fibronectin to serve as adhesion proteins.  This close association of cells via the 
ECM allows for normal cellular activities [for review, see Bernfield, 1981].  
Bernfield [1981] showed in the developing mouse embryo salivary gland that 
epithelial-mesenchymal interaction through the organization and remodeling of ECM not 
only influences morphogenesis, but is reliant on this interaction.  Also critical during this 
process is the presence of a basal lamina for epithelium to anchor to which its structural 
integrity is dependent on GAG.  
The turnover rate of basal lamina GAG is different for various sites of developing 
tissues [Bernfield, 1981].  Sites with a lower GAG turnover rate are indicative of 
quiescence, while areas with a higher GAG turnover rate suggest morphogenetic sites in 
which disruptions in the lamina are present.  Degradation of mesenchymal non-sulfated 
GAG is most apparent at the distant lobules during branching morphogenesis where 
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cells proliferate rapidly, whereas there is less cell proliferation at the glandular clefts and 
lower sulfated GAG turnover rates. 
Spencer and others [1993a] localized GAG distribution during uterine 
morphogenesis in the neonate pig through antibody staining.  These authors found that 
at PND 0, GAG staining was uniform throughout the uterus.  By PND 7, the GAG 
distribution was well defined in the shallow stroma beneath the LE, in clefts at the LE 
and GE junctions, and in stroma bordering the developing necks of glands.  This pattern 
persisted through PND 28, but staining intensity was weakened by PND 56.  These data 
are consistent with the theory that areas that are morphogenetically inactive and stable 
will exhibit the more intense GAG staining, whereas the areas with high GAG turnover 
rates and morphogenetic activity exhibit lesser staining.  
The distribution of ECM collagen during regulation of glandular morphogenesis is 
critical for structural integrity of the tissue by reducing basal lamina GAG degradation 
[Spencer et al., 1993a].  Furthermore, the ECM can control the cell cycle, apoptosis, and 
epithelial gene expression to ultimately influence branching morphogenesis [Gray et al., 
2001b].   
Changes in interactions between biochemical communication pathways 
Cell communication between the epithelium and mesenchyme in the uterus is 
both paracrine and autocrine [Cooke et al., 1998; Taylor et al., 2001; Gray et al., 2001b].  
Epithelial cell proliferation, differentiation, branching morphogenesis, cell migration, ECM 
synthesis and degradation, and angiogenesis are all effected by growth factors and their 
receptors [Sharpe and Ferguson, 1988; Gray et al., 2001b].   
Stromal Growth Factors 
Stromal-derived growth factors are essential for gland proliferation, 
differentiation, branching morphogenesis, and tissue remodeling in epithelial-
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mesenchymal organogenesis [Taylor et al., 2001].  Stromal paracrine factors involved 
with gland morphogenesis include fibroblast growth factor (FGF)-7 [Igarashi et al., 1998], 
FGF-10 [Yamasaki et al., 1996; Beer et al., 1997; Bellusci et al., 1997], hepatocyte 
growth factor (HGF), transforming growth factor-β (TGF-β) and insulin like growth factor 
(IGF)-I and II [for review, see Taylor et al., 2001].  
The fibroblast growth factors are paracrine growth factors that accelerate 
epithelial cell proliferation and differentiation by interacting with their cell surface 
receptors (FGFR) that initiate tyrosine kinase activity [for review, see Powers et al., 
2000].  Cell surface heparan sulfate proteoglycan (HSPG) serves as a co-receptor for 
complete FGFR activation [Dillon et al., 2004]. 
Expression of FGF-7 is localized primarily to the stromal component (tunica 
muscularis) of blood vessels in endometrium and myometrium of the adult ewe [Chen et 
al., 2000] but not detectible in neonatal uteri, despite continuous mRNA expression from 
PND 1 to 56 [Taylor et al., 2001].  In the neonatal ovine uterus, the receptors are 
expressed only in the LE on PND 1, then expression becomes abundant in the GE 
between PND 7 and 56 [Taylor et al., 2001].  Data of FGF-7 ligand and receptor 
transcription in mouse tissue suggests that FGF-7 acts in a paracrine manner on 
epithelial cells [Beer et al., 1997], since the ligand is primarily produced by fibroblasts 
and endothelial cells, but not epithelial cells, while the receptor is expressed on epithelial 
cells.  The role of FGF-7 during neonate uterine adenogenesis is likely for initiating 
epithelial cell proliferation [Taylor et al., 2001]. 
Fibroblast growth factor-10 was initially isolated from embryonic rat tissues 
[Yamasaki et al., 1996] and proposed to be associated with patterning early branching 
morphogenesis of the lung [Bellusci et al., 1997].  Fibroblast growth factor-10 is primarily 
cell- or ECM-associated [Igarashi et al., 273], mitogenic for epithelial cells, and binds to 
both FGFR1IIIb and FGFR2IIIb [Powers et al., 2000].  In the rat lung, FGF-10 is a short-
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range signal and puts forth only a modest effect during lung epithelial bud development 
[Park et al., 1998].  This is evident when FGF-10 alone was not adequate to completely 
promote lung bud migration, but was completed upon the addition of FGF-7 [Park et al., 
1998].  Based on the function of FGF-10 in the lung, a hypothesis regarding neonate 
uterine adenogenesis can be developed.  In the cyclic and pregnant ovine uterus, FGF-
10 is expressed in the endometrial stroma, while its receptor is localized only to the 
epithelium [Chen et al., 2000].  Gene expression of FGF-10 in the neonatal ovine uterus 
did not change from PND 1 to 21 but increased after PND 21 [Taylor et al., 2001], the 
time when branching morphogenesis occurs [Wiley, et al., 1986].  Taylor and coworkers 
[2001] suggested that FGF-10 serves as a chemotactic molecule to stimulate gland 
budding in neonate uteri. 
Hepatocyte growth factor serves as a paracrine factor to mediate paracrine 
epithelial-mesenchymal interactions during morphogenesis of the lung [Rubin et al., 
1991] and mammary gland [for review, see Pollard, 2001].  The c-met proto-oncogene 
product mediates the mitogenic, motogenic, and morphogenic actions of HGF [Bottaro et 
al., 1991].  Gene expression of HGF increased after PND 21 similar to FGF-10 during 
ovine uterine gland branching morphogenesis, implying a synergistic effect between 
FGF-10 and HGF [Taylor et al., 2001].  Tissue expression of HGF receptor c-met is 
localized to the LE and upper GE in the stratum compactum of the neonatal ovine 
uterus. 
Transforming growth factor-β is a cytokine with many functions and activities that 
include cell-cycle control, regulation of early development, differentiation, extracellular 
matrix formation, immune functions, and the induction of apoptosis [for review see 
Norbert and Krieglstein, 2002].  It binds to its membrane-bound receptors, TGF-β 
receptor I and II.  Synergistic effects of TGF-β with other growth factors is one possible 
explanation for its multifunctional properties.  During development of the mouse 
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mammary gland, TGF-β is necessary for regulation of side branching during branching 
morphogenesis.  It has been shown to be down-regulated at sites where side branches 
have begun to form.  When TGF-β receptor signaling is inhibited in the mouse mammary 
gland, excessive duct branching occurs [Wiseman and Werb, 2002].   
Insulin-like Growth Factors 
Insulin-like growth factor I and II are structurally similar to proinsulin and possess 
insulin-like effects [Wang and Chard, 1999].  Both IGF-I and II are synthesized de novo 
in multiple tissues and exhibit mitogenic effects in the tissue via autocrine and/or 
paracrine mechanisms.  Furthermore, the IGF system can mediate tissue response to 
steroids, such as the effects of estrogen on the growth and development of the rodent 
uterus [Murphy and Ghahary, 1990]. 
Insulin-like growth factor I is primarily produced by the liver and its secretion is 
mediated by growth hormone (GH) action through its receptor (GHR) [Wiseman and 
Werb, 2002].  Type I (IGF-IR) and type II (IGF-IIR) IGF cell membrane receptors mediate 
the biological effects of IGF-I and II.  Type I receptors have a high affinity for IGF-I 
binding, but also bind IGF-II and insulin at higher concentrations.  Type II receptors bind 
only IGFs, and have a higher affinity for IGF-II [Wang and Chard, 1999].   
Research has indicated the necessity of IGF-I for normal development of the 
reproductive system of both sexes [Baker et al., 1996].  The absence of IGF-I in female 
mice inhibits myometrial maturation and development of graafian follicles on the ovaries 
[Cerro and Pintar, 1997].  Follicular content of IGF-I increases in the pig after treatment 
with gonadotropins or GH, whereas IGF-II concentrations remain unchanged [Hammond 
et al., 1993].  Expression of IGF-I and –II is localized to the stroma of the adult ovine 
uterus and IGF-IR is expressed in all cell types of the uterus, aiding in maintenance of 
gland development and proliferation [Taylor et al., 2001]. 
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In the developing mouse mammary epithelium, IGF-IR is needed for duct 
development [Kleinberg, 2000].  In this situation, GH activates GHR in the mammary 
stroma which induces stromal IGF-I expression to act on IGF-IR in the epithelium.  Both 
IGF-I and -II serve as paracrine growth factors during uterine epithelial morphogenesis 
[for review, see Taylor et al., 2001]. 
Presence of insulin-like binding proteins (IGFBPs) can either inhibit or enhance 
IGF activity and function independent of the IGFs [for review see Rosenzweig, 2004].  
There are currently six known IGFBPs, which individually can have different tissue 
distribution, binding affinity for the IGFs, and tissue-specific functions [Cerro and Pintar, 
1997; Wang and Chard, 1999; for review see Rosenzweig, 2004].  It is likely that 
IGFBPs function close to their sites of synthesis in an autocrine or paracrine manner 
[Cerro and Pintar, 1997].  
Cerro and Pintar [1997] localized IGFBPs in the cycling and pregnant rat uterus 
and placenta with in situ hybridization.  In the cycling rat, they detected IGFBP-1 in the 
deep endometrial glands, and expression was essentially absent in the LE and 
superficial glands near the lumen.  Both IGFBP-1 and -2 possess a short tri-peptide 
segment that contains the sequence Arg-Gly-Asp (RGD peptide).  The RGD peptide is 
associated with cell adhesion by localizing to the ECM and interacting with β1-integrin 
cell surface receptors and fibronectin.  It is postulated that IGFBP-1 can promote cell 
motility by hindering fibronectin-integrin binding [Cerro and Pintar, 1997].   
Growth factors may also be involved in the epithelial-mesenchymal interactions 
by signaling through ECM molecules [Sharpe and Ferguson, 1988].  Growth factors can 
also have opposing effects on the epithelium and mesenchyme.  In the mesenchyme, 
TGF-β can promote the synthesis of ECM molecules; whereas in the epithelium, it can 
promote the synthesis of cell adhesion molecule receptors [for review, see Sharpe and 
Ferguson, 1988].  In essence, one growth factor can create a system that allows for 
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epithelial-mesenchymal interactions through the ECM and receptors [Sharpe and 
Ferguson, 1988]. 
Interactive biochemical communication factors and receptors 
Regulation of uterine growth in is independent of ovarian steroids from birth to 
PND 60 [Wu and Dziuk, 1988; Spencer et al., 1993a].  Ovariectomy (OVX) at PND 20 
and PND 60 did not influence uterine length, weight, or diameter [Wu and Dzuik, 1988].  
Tarleton et al. [1998] indicated that not only is uterine growth in the neonate pig 
independent of the ovary up to PND 60, but uterine adenogenesis is also not inhibited 
before PND 120 in OVX gilts.  These results are similar to those reported in the neonatal 
ovine uterus [Bartol et al., 1988b; Ott et al., 1998] which suggests endogenous 
estrogens may be involved in branching morphogenesis, but not differentiation of the 
uterus.  In addition to the role of endogenous, non-ovarian estrogens, expression of 
estrogen receptor alpha (ERα)-positive epithelial cells in GE of budding and proliferating 
uterine glands of sheep have been shown to be required for uterine gland development 
[Tarleton et al., 1998]. 
Estrogen 
Estrogens regulate growth, differentiation, and function of many reproductive 
tissues.  Estrogens are involved in the proliferation of cells and can modify cell 
characteristics by inducing growth factors and their respective receptors 
[Katzenellenbogen, 1996].  Many physiological processes that are tissue and organ 
specific, including tissue growth, differentiation, protein synthesis, and secretion are 
regulated through estrogen [Korach, 1994; Katzenellenbogen, 1996].  
Spencer and coworkers [1993b] treated neonatal gilts with estradiol-17β valerate 
(EV) for 7 days prior to hysterectomy on PND 7, 14, or 49.  Periods of EV exposure were 
selected to include the 1) infantile period which is correlated with the appearance or 
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initiation of uterine gland development from birth through PND 7, 2) proliferative period 
from PND 7–14 when there is intense glandular DNA synthesis, and 3) growth period 
after PND 14 when endometrial morphogenetic activity declines and the uterine 
histoarchitecture becomes stabilized.  Uteri from the treated animals displayed increased 
endometrial thickness at PND 7 and 14, as well as an increase in myometrial thickness 
at PND 49.  Distribution of uterine glands was apparent as they were less dense and 
less tightly coiled when compared to control animals at PND 49.  The uterotropic effects 
of estrogen were more apparent with treatment after PND 14, when uterine growth is 
typically the greatest.   
Responses of the neonatal uterus to exogenous estrogen imply an age-related 
sensitivity to the steroid in uterine tissues.  Spencer and coworkers [1993b] suggest 
these morphogenetic responses may be an indication that 1) estrogen-sensitive cell 
populations develop first in the endometrium, 2) estrogen-induced abnormalities in the 
proportion of epithelium to stroma effect later uterine development, and 3) uterine 
tissues are responsive to estrogen.  These researchers demonstrated that EV interrupts 
normal neonatal uterine developmental patterns based on exposure to estrogen during 
the infantile, proliferative, or growth period of uterine morphogenesis. 
Antiestrogens are capable of antagonizing the effects of estrogen by binding to 
the ER without activating the receptor [Katzenellenbogen, 1996].  In cases of ER-
containing breast cancer, antiestrogens are effectively able to suppress metastatic 
activity and cellular proliferation.  There are two types of antiestrogens 1) Type I which 
are partial agonists/antagonists and 2) Type II which are complete/pure antagonists.  
Antiestrogens can be either steroid or non-steroid compounds.  Actions of antiestrogens 
competitively bind ER then modify the ER structure so the receptor cannot effectively 
activate gene transcription [Katzenellenbogen, 1996].   
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Treatment of rats with antiestrogen tamoxifen at different stages of neonatal 
development has profound effects on uterine differentiation, dependent upon time and 
dose of administration.  Branham and coworkers [1985] treated rats at three different 
stages of postnatal development: 1) neonatal from PND 1-5, 2) infantile from PND 10-
14, and 3) immature from PND 20-24.  Uterine weight gain was not affected by early 
exposure to antiestrogen during the neonatal stage, but uterine gland development was 
inhibited.  Tamoxifen treatment during the infantile stage increased uterine weight while 
the number of glands was decreased, and persisted through maturation.  Exposure to 
tamoxifen from PND 20-24 caused an increase in uterine weight, but had no effect on 
number of uterine glands.  These effects may be due to nuclear ER binding of the 
antiestrogen for an extended period of time, resulting in a short-term inhibition of gland 
development.  However, disruption of gland development persists through maturation 
indicating permanent actions of antiestrogen on the developing rat uterus [Branham et 
al., 1985].  
Estrogen Receptor 
Estrogen receptors function as ligand-inducible transcription factors to mediate 
the effects of estradiol, its natural ligand [Couse et al., 1995; Katzenellenbogen, 1996].  
The age-specific effects of estrogen on uterine gland development are likely due to 
estrogen-induced, negative regulation of ERα expression [Gray et al., 2001b].  Tarleton 
and coworkers [1998] characterized the development of ERα expression in the neonatal 
pig endometrium during the first 120 PND.  Age-related changes were observed with 
immunohistochemical detection of ERα protein in the GE, LE, and stroma.  Results 
indicate ERα-negative cell populations in the neonate porcine uterus at birth.  By PND 
15, GE showed intense ERα staining with minimal staining in the LE.  Nuclear ERα 
staining became more intense in the GE of tissues from PND 30, 60, 90, and 120 while 
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LE ERα staining remained weak.  Stromal ERα staining also steadily increased from 
PND 15 to PND 120.  Essentially, endometrial ERα expression patterns change 
positively in relation to age.  The same expression patterns were observed in OVX gilts, 
reinforcing the suggestion that neonatal uterine growth and development is ovary-
independent from birth to PND 60.  Moreover, these immunohistochemical findings 
indicate that ER-positive expression appears first in the GE and stroma, then in LE after 
PND 30. 
Tarleton and coworkers [1998] suggested that in the neonatal pig uterus stromal 
ERα are necessary for endometrial cell proliferation, epithelial and stromal ERα are 
essential for morphogenesis and cytodifferentiation, and together these processes allow 
for endometrial growth and functional phenotypical organization of a mature uterus.  
Furthermore, cellular changes from ERα-negative to ERα-positive is an indication of GE 
differentiation of in the neonate pig uterus [Tarleton et al., 1999].  The results of Tarleton 
and coworkers [1998] in conjunction with the patterns of increased DNA synthesis in GE, 
decrease in LE [Spencer et al., 1993a], indicate a spaciotemporal relation to the 
emergence of uterine glands.  These developmental relationships imply that ERα is 
needed for normal early postnatal uterine growth and adenogenesis in the pig, but is 
estrogen independent [Tarleton et al., 1998].  Early cellular growth via ERα may be 
through stromal secretion of growth factors such as IGF-I and EGF [Cooke et al., 1998].   
Estrogen Receptor Knockout Model 
Lubahn and coworkers [1993] disrupted ERα gene expression with homologous 
recombination to generate mice without functional ERα.  Offspring homozygous for the 
ERα disruption are known as ERα knockout (αERKO) mice and are functionally ERα-
negative.  Females that exhibit αERKO are healthy but fail to develop a functional 
uterus.  Nonetheless, the uteri do express all of the typical cell types at lower ratios, 
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including fewer gland numbers.  This response is likely mediated through alternative 
regulatory pathways such as the stromal-derived growth factors IGF-I, EGF, and TGFα 
[for review, see Gray et al., 2001b].  
Couse and coworkers [1995] studied the estrogen insensitivity of ERKO female 
mice.  They showed that estradiol binds to the uterus of ERKO females at 3% of wild 
type females, while no binding was detected in other ERKO tissues such as the brain, 
kidney, or liver.  Furthermore, serum levels of estradiol were elevated in ERKO mice 
when compared to wild type mice, due to the absence of ER.  Data from both Lubahn 
and coworkers [1993], and Couse and coworkers [1995] suggest a critical function of 
ERα for normal growth and development of the uterus, necessary for normal fertility in 
female mice.  Female ERKO mice are infertile as they exhibited abnormal ovaries with 
cystic and hemorrhagic follicles, while all major cell types were present in the uterus, but 
were less abundant [Lubahn et al., 1993].   
Tarleton and coworkers [1999] treated neonatal gilts with either an estrogen 
agonist (EV) or antiestrogen (ICI 182,780), which is a type II estrogen antagonist 
[Katzenellenbogen, 1996] to determine whether ERα expression is involved in neonatal 
pig uterine adenogenesis by inhibiting ER function.  Gilts were treated from birth until 
PND 13 or from PND 7 until PND 13 with both compounds.  Results indicated that early 
neonatal exposure to ER antagonist prior to ER-positive expression caused 
antiadenotrophic effects.  Exposure to ICI from birth did not reduce endometrial 
thickness, but stromal cell density increased in the shallow stratum compactum, as well 
as adenogenesis was inhibited, when compared to control animals.  Treatment with the 
ICI compound from PND 7 to PND 13 (the time-period in which glands are normally 
proliferating) did not decrease the depth of glandular penetration, but did decrease the 
total endometrial thickness by influencing the organization in the stroma.  Conclusions of 
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this study imply that an activated ER system is necessary for normal uterine 
adenogenesis in the pig [Tarleton et al., 1999]. 
An operational ERα system may strengthen target cell responsiveness to 
uterotropic growth factors.  The ER-positive phenotype in the neonatal uterus may 
dictate the degree of responsiveness to local uterotrophic factors that affect uterine 
growth and endometrial maturation via estrogen-independent, membrane-initiated, ER-
coupled pathways [Tarleton et al., 1998]. 
2.4 Regulation of Porcine Uterine Gland Function 
Secretory activity of the uterine glands during the estrous cycle in the pig is 
restricted to the mid to late luteal phase.  The presence of the conceptuses during 
pregnancy then influence whether additional energy will be used for endometrial 
secretions [Bazer et al., 1984].  During early pregnancy, conceptuses migrate from the 
oviducts into the uterine horns about 60-72 hours post-estrus [Dhindsa et al., 1967]. 
Once conceptuses develop to the blastocyst stage around Day 5 of gestation, they begin 
to hatch from the zona pellucida on Day 8.  Prior to attachment to the uterine surface, 
conceptuses undergo a distinct morphological transformation from spherical (3 to 10 
mm) to tubular (10 to 50 mm) to filamentous (>100mm) morphology between Days 10 to 
13 of gestation [Perry and Rowlands, 1962].  Rapid trophoblast elongation throughout 
the uterine horns functions to increase placental surface area for maximal nutrient 
uptake for the conceptus and stimulation of the uterine luminal surface with estrogen.  
Geisert and coworkers [1982] indicated that recoverable estrogens from pregnant 
uterine flushings were correlated with stage of conceptus development.  Increased 
uterine content of conceptus estrogen following trophoblastic elongation modifies 
endometrial PGF2α movement so that its secretion remains exocrine and sequestered in 
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the uterine lumen [Bazer et al., 1984].  Uterine luminal retention of PGF2α prevents its 
entry into the uterine venous drainage, thus blocking the trigger to luteolysis  [Bazer et 
al., 1984; Geisert et al., 1994].  Peripheral plasma estrogen levels appear to be 
unchanged during this time, but estradiol concentrations are greater in the utero-ovarian 
vein plasma and uterine flushings [Zavy et al., 1980].  Concentrations of PGF2α in utero-
ovarian vein do not change in early pregnancy, unlike Days 13 and 17 of the estrous 
cycle which increased release of endometrial PGF2α cause luteolysis.  In response to 
conceptus estrogens and secretions, CL are maintained and progesterone release 
maintained.  Therefore, estrogen is the proposed maternal recognition of pregnancy 
signal in pigs [Geisert et al., 1982c]. 
Effects of estrogen and progesterone upon the porcine uterus are regulated by 
interaction with their receptors, ER and PR [Geisert et al., 1993; Geisert et al., 1994].  
Indeed, survival of conceptuses during early pregnancy is dependent upon conceptus 
estrogen synthesis to stimulate endometrial ER.  Endometrial ER expression changes 
during the estrous cycle and early pregnancy [Geisert et al., 1993].  During the follicular 
phase of the estrous cycle, ER is localized to the surface and glandular epithelium, and 
stroma.  Once ovulation occurs, stromal ER expression is undetectable.  Loss of the 
stromal ER is likely a result of progesterone-dependent inhibition during pregnancy.  
Endometrial ER is expressed differentially in tissue types after Day 12 of the estrous 
cycle as glandular ER is decreased, but ER, although decreased, persists in the surface 
epithelium.  Surface endometrial ER at Days 10 and 12 of the estrous cycle allows 
conceptuses to influence the uterus via interaction between conceptus estrogen 
secretion and endometrial ER [Geisert et al., 1993], so that pregnancy can be 
successfully established [Geisert et al., 1994].  During early pregnancy, endometrial ER 
protein, mRNA synthesis and surface epithelium ER are maximal on Day 10 to 12 
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[Geisert et al., 1993].  There is an acute increase in conceptus estrogen synthesis during 
the period of rapid trophoblast elongation [Geisert et al., 1982c] followed by a second 
prolonged increase of conceptus estrogen from Day 15 to 30 of gestation which provides 
for maintenance of CL beyond Day 30 of gestation [Geisert et al., 1993]. 
The initiation of progesterone-induced secretory gene expression is dependent 
upon PR expression.  Geisert and coworkers [1994] immunologically localized PR 
expression throughout the estrous cycle and early pregnancy in the pig.  These 
researchers indicated that cellular PR was highest in the endometrium on Day 0 and 5 of 
the estrous cycle, then decreased by Day 10.  Immunological staining was greatest in 
the surface and GE on Day 5 of the estrous cycle, then was undetectable by Day 12.  
However, PR was detected at Day 10 in deep GE.  Stromal PR was detected throughout 
the cycle, becoming more intense over time until Day 18, and maintained throughout 
early pregnancy.  The decrease in epithelial PR from Day 5 to 15 in the estrous cycle is 
likely a progesterone-induced down-regulation of PR [Geisert et al., 1994; Gray et al., 
2001b]. 
2.5 Endometrial Secretions During the Estrous Cycle and Early 
Pregnancy 
Histotroph, also known as uterine milk, provides nutrients to the developing 
conceptus.  Species in which conceptuses form a noninvasive type of placental 
attachment, including the pig, do not come into direct contact with maternal blood supply 
so an alternative source of early nutrition is required [Roberts et al., 1993].  Pig 
conceptuses do not complete placental attachment until around Day 18 of pregnancy, so 
nutrients via histotroph are crucial for conceptus vitality [Geisert et al., 1982a].  A large 
assortment of endometrial proteins are secreted in response to progesterone [Roberts et 
al., 1993].  Endometrial epithelial cell secretions are released into the uterine lumen to 
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supply developing conceptuses with necessary nutrition for survival and prevent 
regression of the CL in order to establish an epitheliochorial placentation [Geisert et al., 
1982a].   
Corner [1921] described the changes in the mature sow uterus throughout the 
estrous cycle and early pregnancy.  He postulated that the secretions observed during 
the first 8 to 10 days of pregnancy, when embryos are spherical in shape, are necessary 
for “flotation of the delicate embryonic vesicles” to assist intrauterine migration and 
spacing.  Fortunately, based on current literature, the roles of the uterine secretions are 
now better understood.  Closer observation indicates that these secretory products serve 
as enzymes, transport molecules, and possibly regulate genetic activity [Bazer, 1975].  
Patterns of uterine protein secretions are indicative of stage of the uterine 
microenvironment during preimplantation [Beier, 2000] and change quantitatively and 
qualitatively throughout the estrous cycle [Bazer, 1975].  Based on these patterns, 
uterine receptivity of attaching blastocysts can be predicted.  Alteration of the uterine 
secretion patterns will result in an unreceptive environment of the uterus for 
conceptuses.  Administration of estradiol benzoate (EB) to rabbits 6 and 20 h post 
insemination caused a delay in uterine secretory patterns, resulting in total failure of 
blastocyst implantation [Beier, 2000].  When pregnant gilts were administered EV on 
Days 9 and 10, plasma progesterone was not changed and viable filamentous 
conceptuses were present on Day 12 and 14, but were degenerated by Day 16 [Morgan 
et al., 1987].  However, pseudopregnancy can be induced in cycling gilts by 
administration of exogenous estradiol from Day 11 to 15 [Geisert et al., 1987].  This early 
exposure to EV leads to an early release of calcium, protein, and uteroferrin into the 
uterine lumen [Morgan et al., 1987].  Advancing the uterine secretions in pregnant gilts 
disrupts the temporal relationship between maternal endometrium and developing 
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conceptuses.  A synchronized uterine environment of secretory patterns is necessary for 
successful conceptus development [Beier, 2000]. 
Bazer [1975] stated that the changes in uterine protein secretions are related to 
three significant physiological events:  1) they are secreted during the luteal phase when 
plasma progesterone concentrations are maximum then decrease with decrease in 
plasma progesterone, 2) changes take place when conceptuses begin to rapidly 
elongate, 3) and when the CL begin to regress in cyclic animals on Day 16. 
Steroid hormones are responsible for the regulation of porcine uterine protein 
secretions.  Ovariectomized gilts treated with progesterone have an increased amount of 
recoverable protein from luminal fluid, indicating responsiveness of endometrium to 
progesterone [Knight et al., 1973].  As expected, the total recoverable protein correlates 
with the number of CL [Knight et al., 1973].  Bazer [1975] concluded progesterone is the 
primary regulator for the synthesis and/or secretion of uterine proteins in the pig. 
In metestrus, uterine glands of the mature, open gilt change from slightly 
branched to more coiled [Sinowatz and Friese, 1983].  The neck and middle part of the 
glands begin to secrete histotroph in early diestrus.  Secretions are apparent at the distal 
ends of glands near the end of diestrus, then begin to decline in proestrus.  Uterine cells 
also undergo changes throughout the estrous cycle, corresponding with endometrial 
secretions [Sinowatz and Friese, 1983].   
In early pregnancy, endometrial secretions are thought to have a paracrine effect 
on the trophoblast [Bell, 1988] and are essential for conceptus development beyond the 
early blastocyst stage [Bazer, 1975].  Pig conceptuses begin to produce estrogen at the 
10 mm late spherical stage (around 11.5 days) which may be the trigger for the 
endometrium to begin secretory release [Geisert et al., 1982a; Bazer and Roberts, 
1983].  This period of conceptus estrogen production is at the same time that the 
maternal recognition of pregnancy occurs and is just prior to conceptus elongation 
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[Geisert et al., 1982a].  Conceptus estrogen may function to induce endometrial 
histotroph secretion as a nutrient source.  This is evident from uterine flushing from 
pregnant gilts in which there was a change in calcium, protein, PGF, and PGE patterns 
[Geisert et al., 1982a].  Conceptus synthesis of estrogen then decreases on Day 13 and 
14, which is evident by continually increased recoverable protein in uterine flushings 
[Geisert et al., 1982a; Geisert et al., 1990].  Geisert and coworkers [1982a] concluded 
that the role of conceptus estrogen on Day 12 of pregnancy is for the initial release of 
specific uterine proteins then later to adjust the uterine protein synthesis and/or 
secretion.  There is a second surge of conceptus estrogen synthesis after Day 14, which 
continues to Day 30 of gestation.  The biphasic release of conceptus estrogen is 
involved in the timing of uterine secretions and PGF2α movement from endocrine to 
exocrine control such that PGF2α is sequestered in the uterine lumen and cannot reach 
the CL via uterine vasculature [Geisert et al., 1990] 
Secreted Proteins 
Changes in protein secretion are dependent on the hormonal environment and 
histological changes throughout the reproductive cycle [Bell, 1988].  Uteroferrin is 
detected in pregnant uterine flushings while tubular and Day 12 filamentous blastocysts 
are present [Buhi et al., 1979], correlated with initiation of conceptus estrogen production 
[Geisert et al., 1982a].  Uteroferrin, previously known as purple acid phosphatase (PAP), 
is induced by progesterone and has a high affinity for iron for which it functions to 
transport iron from the maternal endometrium to the conceptus [Bazer and Roberts, 
1983; Bazer et al., 1984].  Uteroferrin is the most abundant glycoprotein synthesized and 
secreted by the GE, accounting for about 15% of uterine polypeptide secretions 
[Clawitter et al., 1990].  Uteroferrin is synthesized by GE and secreted into the uterine 
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lumen on Days 9-13 of the estrous cycle, then begins to decline around Day 14 [Bazer et 
al., 1984]. 
Retinol binding protein (RBP) is a major constituent of histotroph in which 
production is progesterone-dependant [Clawitter et al., 1990].  It is responsible for the 
transport of retinol in the form of vitamin A to conceptuses [Roberts et al., 1993].  Around 
Day 12 of pregnancy, retinol rapidly increases 10 to 50-fold and large amounts of RBP 
mRNA are detected in the endometrium.  This dramatic increase in retinol is likely due to 
inability of the uterus to store retinol, therefore providing an immediate supply to meet 
conceptus requirements for trophoblast elongation [Trout et al., 1992; Roberts et al., 
1993]. 
Lysozyme is a minor component of uterine flushings.  It is responsive to 
progesterone [Roberts et al., 1976], but disproportionate to the amount of protein 
released [Hansen et al., 1985].  As a result, it is uncertain the effect progesterone has on 
lysozyme secretion.  More recent data from postpartum mares indicate increased uterine 
lysozyme concentration may be a sensitive indicator of endometrial inflammation [Reilas 
and Katila, 2002].  In the human, lysozyme mRNA is upregulated in the regenerating 
crypt base epithelial cells of colonic adenocarcinoma [Yuen et al., 1998].  These patterns 
of lysozyme mRNA and protein expression of different mucosal tissues may be 
indicators of local immune response to prevent bacterial infection [Yuen et al., 1998]. 
Plasmin/trypsin inhibitor (PI), a uterine Kunitz protease inhibitor, has been 
identified in uterine secretions during early pregnancy [Fazleabas et al., 1982].  This 
inhibitor is small and acts to impede actions of plasmin, trypsin, and possibly other 
serine proteinases by limiting damage from release of conceptus proteolytic enzymes 
[Roberts et al., 1993].  Synthesis and secretion of PI is influenced by progesterone, but 
estrogen will work synergistically with progesterone to further control PI [Simmen and 
Simmen, 1990].   
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Lumenal IGF-I concentrations change during the estrous cycle and early 
pregnancy.  The highest uterine luminal content of IGF-I is on Day 10 and 12 which is at 
the period of conceptus estrogen synthesis.  IGF-I may function in a paracrine manner 
during conceptus development since the uterus synthesizes the ligand and the 
preimplantation conceptus expresses IGF-IR.  IGF gene expression in the uterus can be 
divided into two stages: 1) during conceptus elongation when levels of IGF-I mRNA are 
high, IGF-II mRNA levels are low, and IGFBP-3 mRNA levels are low to moderate levels 
and 2) during fetal growth when concentrations of IGF-II and IGFBP-3 mRNA are high 
[Simmen and Simmen, 1990]. 
Other progesterone-responsive proteins secreted in uterine histotroph include 
basic glycoproteins that are family members of the serpin superfamily [Roberts et al., 
1993], which is a family of serine proteinase inhibitors that are similar in amino acid 
sequence and method of inhibition, but differ in function [Silverman et al., 2001].  There 
is also a variety of additional proteins including leucine aminopeptidase, glucose-
phosphate isomerase, beta-glycoprotein (β-glycoprotein) fraction [Bazer, 1975] and 
others that are unidentified [Roberts et al., 1993]. 
2.6 Statement of the Problem 
The dramatic changes that take place throughout the development of the 
neonatal porcine uterus have been proven necessary for later reproductive success.  
Formation of functional uterine glands is a postnatal event in pigs, beginning at birth and 
rapidly completing to functional maturity by 120 days.  The morphological changes have 
been characterized and are regulated by several factors.  Globally, uterine glands are 
essential for the synthesis and secretion of histotroph to support early conceptus 
nutritive requirements.  Interruption of this developmental process is detrimental for 
successive reproduction. 
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The complete transcription profile involved in neonatal uterine adenogenesis is 
unknown at present.  Therefore, the objective of this study was to identify differentially 
expressed genes involved in uterine gland development through comparison of three 
timepoints in postnatal growth.   
2.7 Approach 
Suppression subtractive hybridization (SSH) is a method to compare gene 
expression profiles between various stages of development.  In order characterize 
changes in neonatal uterine gland development, SSH was used to perform a time-point 
analysis for the transcript profiles at three stages: PND 0 when only shallow epithelial 
depressions can be observed, PND 28 when glandular branching morphogenesis 
begins, and Day 56 when endometrial glands are well established. 
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Chapter 3:  MATERIALS AND METHODS 
 
3.1 Neonatal Uteri Collection 
Research conducted was in accordance with and approved by the Oklahoma 
State Institutional Animal Care and Use Committee.  Cyclic, white gilts were observed 
for estrus twice daily using intact boars.  Females were allowed to mate naturally at the 
onset of the first estrus behavior and again 24 hours later.  Gestation was carried out to 
term and day of parturition recorded as postnatal day (PND) 0.  Gilts from each litter 
were randomly assigned to a PND group: PND 0, 14, 28, 42, or 56.  For each respective 
PND, complete, intact uteri were collected from euthanized neonatal gilts.  Neonatal gilts 
were anesthetized with halothane vapor then euthanized by heart-puncture with solution 
of saturated KCl.  The body cavity was opened, the uterus trimmed below the cervix and 
uterine horns removed.  Uteri were trimmed of supporting connective tissue, then snap-
frozen in liquid nitrogen and stored at -80oC until RNA extraction. 
3.2 Total RNA Extraction 
Total RNA was extracted from individual uteri at each PND (0, 14, 28, 42, and 
56) using TRIzol Reagent (Invitrogen, Carlsbad, CA).  Approximately 250 mg of whole 
uterine tissue was homogenized in 2.5 ml of TRIzol reagent using a Virtishear 
homogenizer (Virtis Co. Inc., Gardiner, NY) in a 15 ml conical polypropylene tube.  Then 
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500 µl of chloroform was added, the mixture shaken, and centrifuged at 5,000 x g for 30 
min at 4oC.  The aqueous phase was recovered and 2-propanol added to precipitate 
total RNA at -20oC overnight.  The following day, samples were centrifuged at 5,000 x g 
for 20 min at 4oC to pellet total RNA and the supernatant was discarded.  The pellet was 
washed in 80% ethanol, lightly vortexed, and centrifuged again at 5,000 x g for 10 min at 
4oC.  Ethanol was poured off and the RNA pellet was allowed to air-dry for 10 min.  
Samples were then suspended in 120 µl nuclease-free H2O and stored at  
-80oC until use. 
Total RNA concentration was determined using a LambdaBio spectrophotometer 
(PerkinElmer, Wellesley, MA) to determine absorbance at 260 nm and 280 nm 
(A260:A280).  All uterine total RNA samples had a A260:A280 of 2.0 or greater.  One µl of 
total RNA from each sample was mixed with 8 µl of nuclease-free H2O and 1 µl of 10 x 
gel loading buffer to bring the sample volume to 10 µl.  Products were loaded into a 1% 
agarose gel and allowed to migrate and separate through the agarose at 115 volts (V) 
for 45 min.  The agarose gel was stained in ethidium bromide (EtBr) solution (5 µg/µl) for 
5 min to detect nucleic acids, then rinsed in distilled H2O and imaged using ultraviolet 
(UV) light and Kodak 1D Imaging Software. 
3.3 Isolation of polyA+ RNA 
Poly A+ RNA was isolated from previously purified total RNA using an Ambion® 
(Austin, TX) Poly(A)Purist™ RNA isolation kit.  The absorbance at 260 nm was 
determined and 100 µg of total RNA from the four samples from each day (PND 0, 28, or 
56) were pooled to bring a final concentration of 400 µg per PND.  Volumes were 
brought up to 250 µl with sterile distilled nuclease-free H2O.  An equal volume of 2X 
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binding solution was added and then mixed.  Each pooled RNA sample was added to 
oligo(dT) cellulose and mixed by inverting to resuspend the solution.   
The reaction was heated for 5 min at 75oC to denature secondary structures then 
allowed to shake at RT on a platform shaker for 1 h to allow PolyA+ to bind to the 
oligo(dT) cellulose.  The cellulose was pelleted at 10,000 x g for 3 min and the 
supernatant removed.  Cellulose pellet was washed twice with 500 µl wash solution 1 by 
placing the mixture on a spin column seated in a 2 ml centrifuge tube and centrifuging at 
10,000 x g for 3 min.  The filtrate was discarded and the mixture washed 3X with 500 µl 
wash solution 2 by centrifuging at 10,000 x g for 3 min.  PolyA+ RNA was eluted in 200 
µl of RNA storage solution by spinning at 10,000 x g for 2 min, adding an additional 200 
µl of RNA storage solution, and repeating.  Precipitation was carried out overnight at  
-20oC.   
Messenger RNA was recovered by centrifugation at 10,000 x g for 30 min at 4oC.  
The supernatant was removed and the mRNA pellet washed with 70% ethanol, 
centrifuged for 10 min at 4oC and residual ethanol removed.  The pellet was air dried 
then suspended in 7 µl RNA storage solution.  Concentration of mRNA was determined 
spectrophotometrically.  RNA was stored at -80oC until use. 
3.4 Suppression Subtractive Hybridization 
Suppression subtractive hybridization profiles differentially expressed genes.  
Gene expression differences in neonatal uteri were evaluated with a Clontech™ (Palo 
Alto, CA) PCR Select cDNA subtraction kit.  Two different forward and reverse 
subtractions were performed to compare gene expression during uterine gland 
development between PND 0 and 28, and between PND 28 and 56.  Each SSH 
 36
comparison utilized 2 µg of pooled PND mRNA.  The specific transcripts identified were 
found in the tester population, while the reference cDNA was the driver.  For the PND 0 
vs. PND 28 comparison forward subtraction, PND 0 was the tester and PND 28 the 
driver.  For the reverse subtraction, PND 28 was the tester and PND 0 the driver.  
Likewise in the PND 28 vs. PND 56 comparison, PND 28 was the tester and PND 56 the 
driver in the forward subtraction.  The tester for the reverse subtraction was PND 56 and 
the driver PND 28.   
First Strand Synthesis.  For each experimental and tester PND and control 
PolyA+ RNA (from human skeletal muscle), 2µg of mRNA was mixed with 1 µl of cDNA 
synthesis primer (10µM) and brought to a final reaction volume of 5 µl with 0.1% DEPC-
treated H2O in a 0.2 ml PCR tube.  The reaction was placed in a MJ Research PTC-100 
(Waltham, MA) and heated to 70oC for 2 min, placed on ice for 2 min, briefly centrifuged, 
and then a master mix for the first strand synthesis was prepared.  For each reaction the 
following was added:  2 µl of 5X first strand synthesis buffer (250 mM Tris HCl [pH 8.5], 
40 mM MgCl2, 150 mM KCl, 5 mM dithiothreitol [DTT]), 1 µl of 10 mM dNTP’s, 1 µl 
DEPC H2O, and 1 µl of Avian Myeloblastosis Virus (AMV) reverse transcriptase (20 
units/µl).  Each reaction was mixed, briefly centrifuged, then placed in a PTC-100 for 1 h 
at 42oC.  Afterwards, the reaction was placed on ice while the master mix for second-
strand synthesis was prepared. 
Second-Strand cDNA Synthesis.  Seventy µl of second-strand synthesis master 
mix containing 48.4 µl DEPC H2O, 16 µl 5X second-strand synthesis buffer (500 mM 
KCl, 50 mM ammonium sulfate, 25 mM McCl2, 0.75 mM β-NAD, 100 mM Tris-HCl [pH 
7.5], 0.25 mg/ml BSA), 1.6 µl 10 mM dNTP’s, and 4 µl 20X second-strand enzyme 
cocktail (DNA polymerase I [6 U/µl], RNase H [0.25 U/µl], E. coli DNA ligase [1.2 U/µl]) 
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was added to each first strand synthesis reaction.  The mixture was lightly mixed, 
centrifuged, and placed in a PTC-100 for 2 h at 16oC.  Six units (2 µl) of T4 DNA 
polymerase was added to the reaction and incubated at 16oC for an additional 30 min.  
Products were transferred to a 1.5 ml tube then extracted by adding 100 µl 
phenol:chloroform:isoamyl alcohol (25:24:1), vortexing, and centrifuging at 14,000 rpm 
for 10 min at rt.  The top aqueous layer was removed and the previous step repeated 
using 20 µl of phenol:chloroform:isoamyl alcohol.  In a new 1.5 ml tube, 100 µl 
chloroform:isoamyl alcohol (24:1) was added to the aqueous layer, vortexed and 
centrifuged at 14,000 rpm for 10 min.   
Again, the top aqueous layer was recovered and 50 µl of 4M ammonium acetate 
(NH4OAc) solution and 375 µl of 100% ethanol (EtOH) were added.  Precipitation of 
cDNAs was carried out by vortexing the mixture and centrifuging at 14,000 rpm for 20 
min.  The supernatant was removed, cDNA pellet washed with 500 µl of 70% EtOH, and 
centrifuged for 10 min.  Two additional 70% EtOH washes were performed.  The 
remaining pellet was air dried for 10 min, dissolved in 50 µl of DEPC H2O.  Six µl of the 
second strand synthesis were set aside for analysis by gel electrophoresis.  All products 
were stored at -20oC until later use. 
Rsa I Digestion.  After generation of cDNA for each tester and driver, the 
products were blunt-ended into fragments for optimal subtraction and adaptor ligation.  
To 43.5 µl of the second-strand synthesis, 5 µl of 10X Rsa I restriction buffer (100 mM 
Bis Tris Propane HCl [pH 7.0], 100 mM MgCl2, 1 mM DTT) and 1.5 µl of Rsa I (10 U/µl) 
were added.  The mixture was lightly mixed and incubated at 37oC in a PTC-100 for 3 h. 
Five µl of the digestion were set aside for later analysis by gel electrophoresis.  The 
reaction was stopped by adding 2.5 µl of 20X EDTA/glycogen mix (0.2 M EDTA, 1 mg/ml 
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glycogen), then purified by adding 50 µl phenol:chloroform:isoamyl alcohol (25:24:1) and 
centrifuging for 10 min at 14,000 rpm.  The top aqueous phase was recovered and 
placed into a new microcentrifuge tube.  The previous steps were repeated using an 
additional 20 µl of phenol:chloroform:isoamyl alcohol and the aqueous phase recovered.  
Purification was continued by adding 50 µl of chloroform:isoamyl alcohol (24:1), 
centrifuging for 10 min at 14,000 rpm, and recovering the aqueous phase. 
Precipitation of digested products was initiated by adding 35 µl of 4M ammonium 
acetate (NH4OAc) solution and 262.5 µl of 100% EtOH.  Reaction was mixed and 
centrifuged for 20 min at 14,000 rpm.  The supernate was removed and remaining pellet 
was washed by overlaying with 200 µl of 70% EtOH.  The pellet was centrifuged for 5 
min and the pellet was washed two additional times with 70% EtOH.  The pellet was 
allowed to air dry for 10 min, and then dissolved in 5.5 µl of DEPC H2O.  Digested 
products were stored at -20oC until later use.  Efficiency of the digestion was determined 
by running 2.5 µl of the products on a 1.0% agarose gel at 115 V for 45 min, then 
staining in EtBr, and imaging using UV light.  
Adaptor Ligation.  The ligation of adaptors (Table 3.1) to each Rsa I digested 
tester was necessary for enrichment of differentially expressed sequences for each 
comparison.  For each tester cDNA, there were three adaptor ligations:  Adaptor 1, 
Adaptor 2R, and Unsubtracted Control.  First, 1 µl of the tester cDNA was diluted into 5 
µl of DEPC H2O.  Adaptor master mix was prepared for each ligation, consisting of: 3µl 
DEPC H2O, 2 µl of 5X ligation buffer (250 mM Tris-HCl [pH 7.8], 50 mM MgCl2, 10 mM 
DTT, 0.25 mg/ml BSA), and 1 µl of T4 DNA ligase (400 U/µl). 
Tester cDNA adaptor ligations were set up in a 0.2 ml PCR tube and the 
following added: 2 µl of dilute tester cDNA, 10 µM of either Adaptor 1 (Tester 1-1) or 
Adaptor 2R (Tester 1-2) , and 6 µl of prepared adaptor master mix to bring the reaction 
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up to a total volume of 10 µl.  A third ligation was prepared to serve as the unsubtracted 
control (Tester 1-c).  Two microlters of Tester-1 was mixed with 2 µl of Tester-3 in a new 
0.2 ml tube.  The reactions were mixed and incubated at 16oC overnight in a PTC-100. 
 
Table 3.1.  Sequences of the Clontech PCR-Select cDNA synthesis 
primer, adaptors, and PCR primers. 
Primer Sequence 
cDNA Synthesis 5’-TTTTGTACAAGCTT30N1N-3’ 
Adaptor 1 5’-CTAATACGACTCACTATAGGGC TCGAGCGGCCGCCCGGGCAGGT-3’ 
Nested PCR 1 5’-TCGAGCGGCCGCCCGGGCAGGT-3’ 
Adaptor 2R 5’-CTAATACGACTCACTATAGGG CAGCGTGGTCGCGGCCGAGGT-3’ 
Nested PCR 2R 5’-AGCGTGGTCGCGGCCGAGGT-3’ 
 
Ligation reactions were stopped by adding 1 µl of 20X EDTA/Glycogen mix and 
T4 DNA ligase was inactivated by heating to 72oC for five min.  For each unsubtracted 
tester (Tester 1 and Tester 2), 1 µl was diluted into 1 ml of DEPC H2O and the samples 
were stored at -20oC.  
Efficiency of the adaptor ligation was tested to see whether at least 25% of the 
cDNA’s have adaptors on both ends by diluting 1 µl into 200 µl of H2O and then PCR 
amplifying the adaptors.  The subtraction kit provides glyceraldehyde-3-phosphate 
dehydrogenase (G3PDH) primers that are compatible with human, mouse, and rat 
cDNA.  However, these primers were not useful for amplification of pig G3PDH, so 
efficiency was determined solely based on the control ligation reaction.  A ligation 
analysis master mix was prepared, consisting of the following: 18.5 µl of sterile H2O, 2.5 
µl 10 x BD Advantage™ 2 (Clontech, Palo Alto, CA) PCR reaction buffer (400 mM 
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Tricine-KOH (pH 8.7), 150 mM KOAc, 35 mM Mg(OAc)2, 37.5 µg/ml BSA, 0.05% 
Tween-20, 0.05% Nonidet-P40), 0.5 µl dNTP (10 mM), and 0.5 µl 50 x BD Advantage™ 
2 (Clontech, Palo Alto, CA) polymerase mix (50% glycerol, 15 mM Tris HCl [pH 8.0], 75 
mM KCl, 0.05 mM EDTA).  The four PCR reactions were set up as described in Table 
3.2.  Twenty-two µl of the prepared master mix were added to each tube and briefly 
mixed.  The reactions were placed in a PTC-100 and incubated at 75oC for 5 min to 
extend the adaptors.  The following thermal cycling parameters were then followed: 20 
cycles of 94oC for 30 sec, 65oC for 30 sec, and 68oC for 2.5 min.  Five microliters of the 
PCR products were analyzed on a 1.5% agarose gel, stained in EtBr.  
 
Table 3.2.  Adaptor Ligation Efficiency PCR Setup. 
  
 Tube: 
Component 1 2 3 4 
Tester 1-1 1 1 - - 
Tester 1-2 - - 1 1 
G3PDH 3’ Primer 1 1 1 1 
G3PDH 5’ Primer - 1 - 1 
PCR Primer 1 1 - 1 - 
Total Volume 3 3 3 3 
 
First Hybridization.  Once adaptor ligation has been verified, tester cDNA was 
then hybridized in excess of driver cDNA then heat denatured to generate cDNA that 
can be exponentially amplified using the two new adaptors.  During the first 
hybridization, 1.5 µl of tester (with either Adaptor 1 or Adaptor 2R) was hybridized for 8 h 
with 1.5 µl of Rsa I digested driver cDNA and 1 µl of 4X Hybridization Buffer (Clontech, 
Palo Alto, CA) at 68oC in a PTC-100.  Five different types of molecules form during this 
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hybridization.  Three were cDNAs that cannot amplify because they either have no 
adaptor ligated, only one adaptor ligated, or form a self-dimer. If two molecules bind with 
the same adaptor primer annealing site, the molecule will only amplify linearly.  The fifth 
type of molecule had both Adaptor 1 and Adaptor 2R annealing sites for exponential 
amplification.  
Second Hybridization.  Fresh driver was denatured at 98oC for 1.5 min with 4X 
hybridization buffer and H2O.  Then, each tester with Adaptor 1 and Adaptor 2R were 
mixed together with the excess denatured driver and incubated overnight at 68oC.  
During this step, high and low abundance cDNA sequences were equalized among each 
other.  The following day, 200 µl of dilution buffer (20 mM HEPES-HCl [pH 8.3], 50 mM 
MgCl2, 10 mM DTT, 0.25 mg/ml BSA) was added to each subtraction then stored at  
-20oC overnight.   
PCR Amplification.  The molecules that have both primer annealing sites from 
the subtraction were able to be exponentially amplified during PCR.  Seven PCR 
reactions were set up for the primary PCR: 1) forward-subtraction;, 2) forward 
unsubtracted control, 3) reverse-subtraction unsubtracted control, 4) reverse 
unsubtracted control, 5) subtracted tester control, 6) unsubtracted tester control, and 7) 
PCR control subtracted cDNA.  
A primary PCR master mix was prepared consisting of 19.5 µl sterile H2O, 2.5 µl 
of 10X BD Advantage™ 2 PCR reaction buffer, 0.5 µl of 10 mM dNTP mix, 1.0 µl 10 µM 
PCR Primer 1, and 0.5 mM 50X BD Advantage™ 2 cDNA Polymerase for each reaction.  
Primary PCR reactions were heated to 75oC to extend the adaptors and create a binding 
site for PCR primers.  Thermal cycling parameters were 27 cycles of  
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94oC for 30 sec, 66oC for 30 sec, then 72oC for 1.5 min.  Primary PCR products were 
diluted 3 µl into 27 µl DEPC H2O.   
Secondary PCR.  One µl of each dilute primary PCR product was used as 
template cDNA for secondary PCR.  The secondary PCR master mix was prepared 
containing 18.5 µl sterile H2O, 2.5 µl PCR reaction buffer, 1.0 µl 10 µM nested PCR 
primer 1, 1 µl 10 µM nester PCR primer 2R, 0.5 µl 10 mM dNTP mix, and 0.5 µl 
Advantage cDNA polymerase mix for each secondary PCR reaction.  Thermal cycling 
parameters were 12 cycles of 94oC for 30 sec, 68oC for 30 sec, and 72oC for 1.5 min.   
Primary and secondary PCR products were visualized on a 1.5% agarose gel run 
in 1X TEA and stained in EtBr.  Each subtraction was then enriched for differentially 
expressed cDNA sequences.  Secondary PCR products were stored at -20oC until later 
use. 
Following secondary PCR, cDNA were adenylated to stabilize each sequence.  
Fifteen µl of secondary PCR for each subtraction were mixed with 25 µl of 
chloroform:isoamyl alcohol (24:1), vortexed, and the spun for 5 min at 13,000 rpm.  Ten 
µl of the supernate were recovered, then mixed with 1 µl of dATP (Applied Biosystems, 
Foster City CA), 1 µl Advantage PCR reaction buffer, and 0.5 µl AmpliTaq (Applied 
Biosystems, Foster City CA).  The mixture was placed in a PTC-100 for 10 min at 72oC.  
Four µl of the adenlyated secondary subtracted products were then used for ligation into 
vector.   
3.5 Vector Cloning 
Secondary PCR products were inserted into a TOPO® TA pCR4 (Invitrogen, 
Carlsbad, CA) cloning vector to identify sequences for each insert.  Four µl of each 
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secondary PCR were mixed with 1 µl of salt solution (1.2 M NaCl, 0.06 M MgCl2) and 1 
µl of cloning vector.  The reaction was incubated at RT for 30 min, then placed at 4oC 
overnight.  The following day, 2 µl of the cloning reaction were gently mixed with One 
Shot® TOP10 (Invitrogen, Carlsbad, CA) chemically competent E. coli cells.  The 
reaction was carried out for 30 min on ice and heat shocked at 42oC for 30 sec.  The 
transformation was immediately placed on ice and 250 µl of rt S.O.C. Medium (2% 
tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 
20 mM glucose) was added.  Each reaction was capped and shaken for 2 h at 37oC.  
Fifty or 100 µl from each transformation was spread onto prewarmed selective agar 
plates (LB agar, 100 mg/ml carbenicillin, 18 mg/ml X-GAL, 7.2 x 10-5 M IPTG).  Plates 
were placed in a 37oC incubator (Fisher Scientific, Pittsburg, PA) inverted for 16 h. 
Small, white colonies were picked the following day using sterile toothpicks.  
Each colony was streaked onto a new pre-warmed selective agar plate, placed into 2 mL 
of Terrific Broth (12 g Bacto® tryptone, 24 g yeast extract, 2.31 g KH2PO4, 12.54 g 
KH2PO4) (Fisher Scientific, Pittsburg, PA) with 100 µg/ul carbenicillin for plasmid 
extraction, and in 700 µl Terrific Broth with 300 µl 90% glycerol for back-up storage at  
-80oC.  Agar plates with plasmids were incubated overnight at 37oC, plasmids in Terrific 
Broth were incubated in a shaking incubator (New Brunswick Scientific, Edison, NJ ) for 
16 h.  
3.6 Plasmid extraction 
Plasmid DNA was purified in a 96-well format using Wizard® SV 96 System 
(Promega, Madison, WI).  Bacterial cells were pelleted by centrifuging for 15 min at 
1,500 x g then pouring off the supernate and blotting upside down.  Cells were 
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resuspended in 250 µl of resuspension solution (50 mM Tris-HCl [pH 7.5], 10 mM EDTA, 
100 µg/ml RNase A), 250 µl of cell lysis solution (0.2M NaOH, 1% SDS) added, mixed, 
then incubated 3 min at rt.  Neutralization solution (4.09 M guanidine hydrochloride, 
0.759 M potassium acetate, 2.12M glacial acetic acid) was added (350 µl) and the total 
mixture was transferred to a prepared vacuum manifold (Promega, Madison, WI) 
assembled with a lysate clearing plate and a DNA binding plate (Promega, Madison, 
WI).  Lysates were allowed to sit on plate for 1 min, and then vacuum was applied for 5 
min.  An additional 500 µl of neutralization solution was added to each well and vacuum 
was applied for 1 min. 
Each well was washed with 1.0 mL of wash solution (162.8 mM potassium 
acetate, 27.1 mM Tris-HCl [pH 7.5], 95% EtOH), vacuum applied for 1 min, and the 
process repeated.  The plates were dried by applying vacuum for 10 min.  The vacuum 
manifold was dissembled to remove the DNA binding plate and then blotted on paper 
towels to remove residual EtOH.   
The DNA binding plate was placed on the vacuum manifold, above an elution 
plate (Promega, Madison, WI) and 100 µl of DEPC H2O added to each well in the 
binding plate.  The plate was incubated for 1 min at rt, then vacuum applied for 1 min.  
Plasmid DNA was now eluted and ready for quantification.   
Concentrations of purified plasmid cDNAs were fluorescently quantified using 
PicoGreen® quantitation reagent (Molecular Probes, Eugene, OR).  TE Buffer (100 mM 
Tris-Hcl [pH 7.5], 10 mM EDTA) was diluted to 1X and a working solution of PicoGreen 
was prepared by making a 200X dilution.  Two microliters of each purified cDNA sample 
was diluted in 73 µl of 1X TE Buffer then mixed with 75 µl of dilute PicoGreen reagent.  
A standard curve was generated using a lambda DNA standard in duplicate.  
 45
Fluorescence was quantified using a PerkinElmer (Wellesley, MA) Wallac Victor2 plate 
reader. 
Immobilizing plasmid DNA.  Plasmid DNA was denatured in a 96-well pate with 
250 µl 0.5 M NaOH and 1.5 M NaCl for 10 min at rt.  Meanwhile, positively charged 
membranes (Roche Diagnostics, Indianapolis, IN) were pre-wetted in distilled H2O.  Four 
separate Bio-Dotter apperati were assembled, each with one membrane.  Membranes 
were rehydrated by adding 100 µl of denaturing solution (5 M NaCl, 0.5 M NaOH) to all 
96 sample wells and gentle vacuum applied to remove the buffer.  Seventy-seven 
microliters of denatured DNA were added to each sample well and bound to membrane 
with gentle vacuum.  Sample wells were rinsed with 200 µl neutralization solution (1M 
Tris-HCl [pH 8.0], 1.5 M NaCl) and incubated at RT for 10 min, followed with gentle 
vacuum.  All membranes were removed from each Bio-Dotter, placed on 2X SSC-
soaked blotting paper, then UV-crosslinked to fix the cDNA onto membranes.  All 
membranes were stored at 4oC until use.   
3.7 Differential Screening 
Individual clones were confirmed for differential expression using the DIG High 
Prime DNA Labeling and Detection Starter Kit II (Roche Diagnostics, Indianapolis, IN).  
This method uses digoxygen (DIG) to label secondary PCR products from each SSH 
comparison, both subtracted and unsubtracted products, forward and reverse. 
DIG-DNA Labeling 
Four secondary PCR reactions were performed for all SSH comparisons as 
described above in the SSH protocol.  The four individual PCR products for each 
comparison were combined to a total volume of 100 µl and 2.5 µl were used to 
determine A260.  Two micrograms of PCR product were digested with Rsa I enzyme in 
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20 µl volume for 1 h at 37oC.  The restriction digested products were purified using 
QIAquick PCR Purification Kit (Qiagen, Valencia, CA).  Briefly, all 20 µl of the digest 
were mixed with 5 volumes of Buffer PB (Qiagen), mixed, then loaded onto the resin 
column, with 2 ml collection tube.  To bind DNA, the columns were centrifuged for 60 sec 
at 10,000 rpm.  The flow-through was recovered and passed through the column a 
second time.  After the second binding, the flow-through was discarded.  The column 
was placed back into the tube then washed with 750 µl Buffer PE (Qiagen) and 
centrifuged for 60 sec.  The flow-through was discarded, then the column was spun for 1 
min to remove residual ethanol.  Purified DNA products were eluted in 20 µl of H2O by 
centrifugation.  Following purification, A260 was determined and 1 µg of DNA was diluted 
in 16 µl of H2O as template for DIG labeling. 
Template DNA was denatured by heating to 95oC in a PTC-100 for 10 min, then 
chilled on ice.  Four µl of DIG-High Prime were added to the freshly denatured template 
followed by hybridization with template DNA for 20 h.  Hybridization reactions were 
stopped by heating to 65oC for 10 min.  The control DIG labeled DNA was serially 
diluted then spotted onto a positively charged nylon membrane (Roche Diagnostics, 
Indianapolis, IN). 
Labeling was detected immunologically with an anti-digoxygen-AP conjugate.  
The membrane was rinsed in 20 ml maleic acid buffer (0.1 M maleic acid, 0.15 NaCl [pH 
7.5]) for 2 min at RT then transferred to 30 ml blocking solution (Roche Diagnostics, 
Indianapolis, IN) for 30 min at rt.  Membranes were sequentially transferred into 20 ml of 
antibody solution (anti-digoxygen-AP 75 mU/ml in blocking solution) for 30 min, twice for 
15 min in 50 ml of washing buffer (0.1 M maleic acid, 0.15 NaCl [pH 7.5], 0.3% (v/v) 
Tween 20), then equilibrated for 5 min in 10 ml detection buffer (0.1 M Tris-HCl, 0.1 M 
NaCl [pH 9.5]).  The membrane was then placed on a cut open Ziploc bag and 100 µl 
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CSPD-ready-to-use (Roche Diagnostics, Indianapolis, IN) was applied, covered with the 
second sheet of Ziploc, and incubated at RT for 15 min.  Edges of the bag were heat-
sealed and membranes were exposed to x-ray film (X-OMAT LS, Kodak, Rochester, NY) 
for 20 min.  Film was processed automatically with an automatic x-ray film processor 
(Konica, Scarborogh, ME).  Intensity of the spots from each labeling reaction was 
compared with the control spots.  Amount of DIG-labeled DNA was determined and each 
probe was diluted to 25 ng/ml in 8 ml DIG Easy Hyb.  
Hybridization 
Previously prepared cDNA membranes were hybridized with the subtracted or 
unsubtracted cDNA DIG-labeled probes overnight to screen for differentially expressed 
cDNAs.  First, a working solution of DIG Easy Hyb Granules (Roche Diagnostics, 
Indianapolis, IN) were dissolved in 64 ml sterile double distilled H2O and stirred for 5 min 
at 37oC.  Volume of DIG Easy Hyb was determined based on membrane size at a rate of 
10 ml/100 cm2 membrane and preheated to 38oC.  Each membrane (4 per comparison) 
was placed in a roller-bottle and prehybridized for 30 min at 38oC in a rotating incubator.  
Meanwhile, the DIG-labeled probes were denatured in a PTC-100 thermalcycler for 5 
min at 95oC.  Each probe was then added to the pre-heated DIG Easy Hyb (3.5 ml/ 100 
cm2 membrane) and thoroughly mixed.  The prehybridization buffer was recovered and 
replaced with the probe/hybridization mixture.  All membranes were incubated overnight 
with rotation. 
Stringency Washes.  The following day, probe/hybridization mixtures were 
recovered and stored at -20oC.  Membranes were carefully removed from the roller 
bottle and stringency washed twice for 5 min in stringency wash 1 (2x SSC, 0.1% SDS) 
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at RT with constant shaking.  Stringency wash 1 was replaced with stringency wash 2 
(0.5x SSC, 0.1% SDS) prewarmed to 65oC for two 15 min washes with constant rotation. 
Immunological Detection 
After stringency washes, membranes were subjected to immunological detection 
of DIG-labeled probes.  All incubations were carried out at RT on a platform shaker.  
Membranes were first washed for 5 min in washing buffer, incubated for 30 min in 50 ml 
blocking solution, 30 min in 20 ml antibody solution, then washed twice for 15 min in 
washing buffer.  The membranes were equilibrated for 5 min in detection buffer, 
transferred to an opened Ziploc bag, 1 ml CSPD ready-to-use applied, membrane 
covered with second sheet of Ziploc, and incubated for 5 min.  Excess CSPD was 
squeezed out and edges of the bag were heat-sealed.  Sealed membranes were then 
incubated for 10 min at 37oC to enhance luminescence.  Immunologically detected 
membranes were exposed to x-ray film (X-OMAT LS, Kodak, Rochester, NY) for 30-45 
sec and film processed immediately.  Images were saved electronically using a light box, 
digital camera, and Kodak 1D software. 
3.8 EcoR I digestion 
Following extraction, the plasmid cDNAs were digested with EcoR I to determine 
insert size and redundancy within each cloning reaction.  A master mix for all 96 clones 
was prepared, and consisted of 2 µl 10X Buffer H (Promega, Madison, WI) (90 mM Tris-
HCl, 10 mM MgCL2, 50 mM NaCl), 0.2 µl acetylated BSA (10 µg/ul), and 0.5 µl EcoR I 
restriction enzyme (12 U/µl).  One microgram of cDNA was digested and total volume 
was brought up to 20 µl with DEPC H2O.  Digestion was prepared in a 96-well PCR plate 
and placed in a PTC-100 for 4 h at 37oC.  Digested products were analyzed on a 1.5% 
agarose gel run in 1X TAE buffer and stained in EtBr. 
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3.9 DNA Sequencing 
Sequence of plasmids that showed differential expression through differential 
screening were determined using a CEQ 8000 Genetic Analysis System (Beckman-
Coulter, Fullerton,CA).   
Clone cDNA templates were concentrated to 260 ng in 10 µl of sterile H2O then 
heat denatured for 5 min at 86oC in a PTC-100 and placed immediately on ice.  Eight µl 
dye terminator cycle sequencing (DTCS) Quick Start Kit (Beckman-Coulter, Fullerton, 
CA) plus 2µl of sequence primer (5 µm), (either forward or reverse) were added to each 
denatured sample.  The reactions were mixed, spun down, and then placed in a PTC-
100 with the following cycling parameters:  30 cycles of 96oC for 20 sec, 50oC for 20 
sec, 60oC for 20 sec, then held at 4oC.   
The PCR reaction was stopped by adding 5 µl of stop solution (1.5 M NaOAc, 50 
mM EDTA, 20 mg/ml glycogen).  Precipitation followed by adding 60 µl of ice-cold 95% 
EtOH, sealing with aluminum, and centrifuging at 5,700 rpm in an Allegra™ 25 
centrifuge (Beckman-Coulter, Fullerton, CA) for 10 min.  Plate was turned upside down 
to pour off ethanol, then spun inverted at 300 rpm for 20 sec.  The plate was turned 
right-side up, rinsed twice with 200 µl of ice-cold 70% EtOH and pelleted at 5,700 rpm 
and drying at 300 rpm as above.  After removal of residual EtOH, the pellets were 
allowed to air dry for 10 min, then 40 µl of sample loading solution (Beckman-Coulter, 
Fullerton, CA) was added to resuspend each pellet.  The mixture was overlain with 1 µl 




3.10 Sequence Identity 
Each sequence output from the CEQ 8000 Genetic Analysis System was 
identified using Basic Local Alignment Search Tool (BLAST) [Altschul et al., 1990].  
Sequences were first searched for vector contamination using VecScreen (National 
Center for Biotechnology Information) and portions of inserts with contamination were 
not used for BLAST.  
3.11 PCR Primer Design 
Primers for real-time PCR were designed using Integrated DNA Technologies 
(IDT) PrimerQuestSM.  Parameters were limited to an optimum primer size of 24 
nucleotides, TM of 60oC, 50% GC content, products less than 300 bp, no more than 
three runs of Gs, and the five nucleotides at the 3’ end do not have more than two G 
and/or C bases.  Primer pairs were designed for SPARCL1, clone PND 0 vs. PND 28 
#47, and clone PND 28 vs. PND 0 #7.  
3.12 Quantitative Real-Time PCR (qRT-PCR) 
Transcripts for SPARCL1, clone PND 0 vs. PND 28 #47, and clone PND 28 vs. 
PND 0 #7 mRNA were assayed using quantitative real-time PCR (qRT-PCR) and SYBR 
Green I, while endogenous 18S was assayed using a fluorescent reporter.  Neonatal 
uterine tissue from five time points in three developmental stages was assayed: infantile 
(PND 0), proliferative (PND 14), and growth (PND 28, 42, and 56).  Amplification was 
conducted with an Applied Biosystems PRISM® 7500 Sequence Detection System (ABI, 
Foster City, CA).  Total RNA from different PND uteri was assayed in duplicate at a 
concentration of 100 ng for amplification of each target and 18S ribosomal control.   
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Expression of 18S ribosomal RNA was analyzed using a one-step reverse 
transcription qRT-PCR Master Mix for TAMRA®-labeled probe kit (Eurogentec, 
Philadelphia, PA).  Each reaction for TAMRA®-labeled 18S probe consisted of .0625U 
EuroScript reverse transcriptase (Moloney murine leukemia virus) with 0.025U RNase 
Inhibitor, 18S forward and reverse primers (25 nM), 18S 5’ FAM, 3’ TAMRA labeled 
probe (100 nM), and reaction buffer with dNTPs (including dUTP), Hot Goldstar DNA 
polymerase, MgCl2 (5 mM final concentration), stabilizers, and ROX passive reference. 
Amplification of target mRNA expression was detected with a one-step reverse 
transcription qRT-PCR for SYBR Green I (Eurogentec, Philadelphia, PA).  Each target 
reaction final concentration consisted of 0.0625U EuroScript reverse transcriptase 
(Moloney murine leukemia virus) with 0.025U RNase inhibitor and reaction buffer with 
dNTPs, Hot GoldStar DNA Polymerase (0.025U/µl), 5 mM MgCl2, SYBR Green I, ROX 
passive reference.   
Primer Optimization and Melting CurveAnalysis 
Before quantitative differences could be determined, cycling conditions were 
optimized and primer melting curve analysis performed.  Total RNA at a 10-fold 
difference (50 ng and 5 ng) and a no template control (NTC) (0 ng) were analyzed in 
duplicate for each primer pair at 0.5 µM.  Cycling parameters for the each primer melting 
curve analysis were: 1) initial 30 min reverse transcription at 50oC, 2) 15 min 95oC Hot 
GoldStar reverse transcriptase activation, 3) 40 cycles of 95oC for 15 sec, 55oC for 30 
sec, 72oC 20 sec, and 4) an additional extension at 76oC for 34 sec.  Cycling was 
followed immediately by a melting curve analysis with an initial 95oC for 15 sec, 19 min 
and 59 sec annealing ramp time beginning at 60oC to 95oC for a 15 sec denature.  
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Fluorescence data was acquired at the second extension phase and throughout the 20 
min dissociation. 
Melting curves were analyzed using the Dissocation Curve™ software by Applied 
Biosystems (Foster City, CA).  Desired results were a primer set that had a higher, yet 
distinct, TM than the primer-dimers formed in the NTC.  The temperature between the 
primer dimer melting and the target melting was the temperature necessary to collect 
data during a real-time assay.   
Quantitative RT-PCR 
Cycling parameters for the each real-time SYBR Green assay were: 1) initial 30 
min reverse transcription at 50oC, 2) 15 min 95oC Hot Start reverse transcriptase 
activation, 3) 40 cycles of 95oC for 15 sec, 60oC for 1 min, 72oC 1 min, TM for specific 
target for 15 sec (as determined by the melting curve analysis and which was the data 
acquisition step).  A melting curve analysis was also performed immediately following 
each assay. 
Results of qRT-PCR were analyzed using relative quantification and determining 
fold difference.  Microsoft Excel® software was used to determine the difference in cycle 
threshold (∆CT) between the target cycle threshold (CT) and the 18S RNA CT for each 
uterine sample.  Based on the ∆CT, the fold differences in gene transcripts were 
calculated using 2-∆∆Ct.  To determine assay efficiency, a standard curve for each 
reaction plate was generated from the log of the concentration of initial RNA to the CT 
and adding a linear trend line to determine the R2-value. 
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3.13 Statistical Analysis 
The statistical model used for this analysis tested the fixed effect of postnatal day 
(PND 0, 14, 28, 42, and 56).  Quantitative RT-PCR ∆CT was determined for each pig, 
and therefore pig was the experimental unit.  Data were analyzed using PROC MIXED of 
the Statistical Analysis System (SAS).  Significance (P < 0.05) was determined using 
probability differences of Least squares means (LSM) between postnatal days on uterine 
gene expression of SPARCL1, clone PND 0 vs. PND 28 #47, and clone PND 28 vs. 
PND 0 #7. 
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Chapter 4:  RESULTS 
 
4.1 Total RNA Extraction 
Total RNA was extracted from whole uteri at PND 0, 14, 28, 42, and 56 
(n=4/PND).  Quality of RNA was high as determined both spetrophotometrically and 
visually on a 1.0 % agarose gel (Figure 4.1).   
 
Figure 4.1.  Purified total RNA visualized on a 1.0% agarose gel.  Lane 
M:  1 Kb Plus DNA Ladder.  Lanes 1 – 8: One µl of puried total RNA from 
eight different samples.  Bands are apparent for the abundant 28S and 
18S ribosomal RNA around 4.5 kb and 1.9 kb, respectively (arrows). 
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4.2 Suppression Subtractive Hybridization 
Messenger RNA was isolated from total RNA and subjected to SSH to construct 
a subtracted cDNA library enriched in transcripts that were preferentially expressed in 
PND 0 than PND 28 and on PND 28 than in PND 56. 
 
 
Figure 4.2.  Efficiency of adaptor ligation of control reaction visulaized on 
agarose gel.  Lane M) 1 kb plus DNA ladder.  Lane 1) PCR products with 
Tester 1-1 (Adaptor 1 ligated) as the template and G3PDH 3’ Primer and 
PCR Primer 1.  Lane 2) PCR products with Tester 1-1 (Adaptor 1 ligated) 
as the template and G3PDH 3’ and 5’ Primers.  Lane 3) PCR products 
with Tester 1-2 (Adaptor 2R ligated) as the template and G3PDH 3’ 
Primer and PCR Primer 1.  Lane 4) PCR products with Tester 1-2 
(Adaptor 2R ligated) as the template and G3PDH 3’ and 5’ Primers.  Lane 
5) More dilute Tester 1-1 with PCR Primer 1.  Efficiency was determined 
by a shift in molecular weight (MW) when G3PDH was amplified  in 
control cDNA using the PCR Primers (1 and 2R) (top arrow) versus gene 
specific primers (G3PDH) 3’ and 5’ (bottom arrow). 
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Tester and driver cDNA were generated then blunt-ended by Rsa I digestion.  
One of two adaptors were ligated to the cDNA and efficiency was determined based on 
whether there was a detectible shift in molecular weight (MW) between second-strand 
synthesis products and Rsa I digested products of the control reaction (Figure 4.2).  
Subtracted products were successfully amplified as determined visually on a 1/5% 
agarose gel (Figure 4.3).  Abundance of products were low following primary 
amplification, but distinct bands were apparent after secondary PCR.  
 
Figure 4.3.  Secondary PCR of subtracted and unsubtracted products 
visualized on agarose gel.  Subtracted tester and driver cDNA show 
individual bands, whereas unsubtracted tester and driver cDNA show 
streaks.  Lane:  M) 1 kb Plus DNA ladder, 1) PND 0 Tester Subtracted 
cDNA. 2) PND 0 Tester Unsubtracted cDNA ligated with both Adaptors 1 
and 2R. 3) PND 28 Tester (PND 0 Driver) Subtracted cDNA. 4) PND 28 
Tester (PND 0 Driver) Unubtracted cDNA ligated with both Adaptors 1 
and 2R. 5) PND 28 Tester (PND 56 Driver) Subtracted cDNA.  6) PND 28 
Tester (PND 56 Driver) Unsubtracted cDNA ligated with both Adaptors 1 
and 2R. 7) PND 56 Tester Subtracted cDNA. 8) PND 56 Unsubtracted 
cDNA ligated with both Adaptors 1 and 2R.  9) PCR Control Subtracted  
cDNA. 
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4.3 Differential Screening, DNA Sequencing, and EcoR I 
Digestion 
Electronic images of membranes were used to determine differential expression 
based on the criteria in Table 4.1.  In addition to differential screening, all clones were 
EcoR I digested to determine approximate insert size (MW).  Plasmids showed either no 
insert or different molecular weight bands, indicating the presence of multiple inserts 
(Figure 4.4).  A total of 288 SSH products were screened in two forward and reverse 
experiments.  Of these, 67 were identified to be differentially expressed through dot-blot 
hybridization assays using DIG-labeled probes (Figures 4.5-4.8).  Only 34 were 
subjected to sequencing and BLAST analysis. 
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Figure 4.4.  EcoR I digested clone products.  Lane M: 1 Kb Plus DNA 
ladder.  Remaining Lanes (1-19): individual clones digested with EcoR I 
show distinct bands (A. arrow) at MW lower than plasmid DNA (B. arrow).  
Clones with no insert show no distinct band, such as in Panel B, Lane 17.   
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Figure 4.5.  Differential screening analysis of PND 0 versus PND 28 
hybridization assays using DIG-labeled probes.  Differentially screened 
nylon membranes spotted with purified plasmid DNAs from subtracted 
population when PND 0 was the tester and PND 28 was the driver.  
Membranes were probed with A) tester subtracted from driver (forward 
subtracted), B) tester unsubtracted with both adaptors present but no 
driver present, C) PND 28 as tester and PND 0 as driver (reverse 
subtracted), D) reverse unsubtracted (absence of PND 0, driver added 
and both adaptors present).  DIG-labeled probes (25 ng/ml) hybridized 
(42°C overnight), detected through CSPD, and exposed to X-OMAT blue 
film for approximately 30 sec.   
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Figure 4.6.  Differential screening analysis of PND 28 versus PND 0 
hybridization assays using DIG-labeled probes.  Differentially screened 
nylon membranes spotted with purified plasmid DNAs from subtracted 
population when PND 28 was the tester and PND 0 was the driver.  
Membranes were probed with A) tester subtracted from driver (forward 
subtracted), B) tester unsubtracted with both adaptors present but no 
driver present, C) PND 0 as tester and PND 28 as driver (reverse 
subtracted), D) reverse unsubtracted (absence of PND 28, driver added 
and both adaptors present).  DIG-labeled probes (25 ng/ml) hybridized 
(42°C overnight), detected through CSPD, and exposed to X-OMAT blue 
film for approximately 30 sec.   
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Figure 4.7.  Differential screening analysis PND 28 versus PND 56 
hybridization assays using DIG-labeled probes.  Differentially screened 
nylon membranes spotted with purified plasmid DNAs from subtracted 
population when PND 28 was the tester and PND 56 was the driver 
(Clones 1-76).  Membranes were probed with A) tester subtracted from 
driver (forward subtracted), B) tester unsubtracted with both adaptors 
present but no driver present, C) PND 56 as tester and PND 28 as driver 
(reverse subtracted), D) reverse unsubtracted (absence of PND 28, driver 
added and both adaptors present).  DIG-labeled probes (25 ng/ml) 
hybridized (42°C overnight), detected through CSPD, and exposed to X-
OMAT blue film for approximately 45 sec.   
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Figure 4.8.  Differential screening analysis PND 56 versus PND 28 
hybridization assays Using DIG-labeled Probes.  Differentially screened 
nylon membranes spotted with purified plasmid DNAs from subtracted 
population when PND 56 was the tester and PND 28 was the driver 
(Clones 1-18).  Membranes were probed with A) tester subtracted from 
driver (forward subtracted), B) tester unsubtracted with both adaptors 
present but no driver present, C) PND 28 as tester and PND 56 as driver 
(reverse subtracted), D) reverse unsubtracted (absence of PND 0, driver 
added and both adaptors present).  DIG-labeled probes (25 ng/ml) 
hybridized (42°C overnight), detected through CSPD, and exposed to X-
OMAT blue film for approximately 45 sec.   
 
Sequence analysis revealed 25/34 quality readings and 16/25 matched known 
sequences, while 7/25 returned identity to uncharacterized clones, and 2/25 had no 
significant match to any known sequences.  Differential screening results are 
summarized in Table 4.2.  Sequence identity for each subtraction are summarized in 
Tables 4.3 and Table 4.4.  Two clones from the PND 0 vs. PND 28 forward subtraction 
and one from the reverse subtraction were chosen to perform qRT-PCR analysis.  For 
the forward subtraction, clones PND 0 vs. PND 28 #45 (SPARCL1) (Figure 4.5, Panels 
A-D, Lane D, Column 9) and #47 (Figure 4.5, Panels A-D, Lane D, Column 11) were 
selected because each showed labeling on both the forward subtracted and 
unsubtracted membranes, but with lower expression in the reverse subtracted and 
unsubtracted membranes.  Clone PND 28 vs. PND 0 #7 (Figure 4.6, Panels A-D, Lane 
A, Column 7) was chosen as a control since labeling appeared similar on each 
subtracted membrane. 
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Table 4.2.  Summary of differential screening and sequencing of 
subtracted clone libraries. 












PND 0 vs.  
PND 28 
 
> in 0 96 35 17 14 10 4 
 
PND 28 vs. 
PND 0 
 
> in 28 96 19 13 10 6 4 
 
PND 28 vs. 
PND 56 
 
> in 28 78 13 2 1 0 1 
 
Table 4.3.  PND 0 vs. PND 28 clone sequence results. 
Clone ACC. # Name % Match 
PND0v28_5 CN153472 EF1ALPHA 764/776 (98%) 
PND0v28_7 AF304203 Mitochondrion, partial genome 290/300 (96%) 
PND0v28_30 CK463699 EF1ALPHA 344/350 (98%) 
PND0v28_45 BQ604418 Pig uterine clone: similar to human SPARCL1  580/583 (99%) 
PND0v28_47 BP169911 Pig uterine clone:  transcribed sequences 538/541 (99%) 
PND0v28_49 CF367529 Pig uterine clone 163/176 (92%) 
PND0v28_50 AF304203 Mitochondrion, partial genome 205/209 (98%) 
PND0v28_59 BP438017 EF1ALPHA 621/625 (99%) 
PND0v28_70 AB113356.1 Pig clone 345/379 (91%) 
PND0v28_72 BP441417 Pig clone: similarity to human POLR2C 310/310 (100%) 
PND0v28_76 AF304203 Mitochondrion, partial genome 136/144 (94%) 
PND0v28_84 CK456781 Pig clone: similarity to human PABPC1 679/680 (99%) 
PND0v28_95 BP169911 Pig uterine clone: transcribed sequences 513/517 (99%), 
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Table 4.4.  PND 28 vs. PND 0 clone sequence results. 
CLONE ACC. # Name % Match 
PND28v0_6 CB169367 Bos taurus clone 309/371 (83%) 
PND28v0_7 CK458228 Pig embryo clone: transcribed sequences 395/397 (99%) 
PND28v0_8 AJ685413 Pig clone: COL3A1  456/490 (93%) 
PND28v0_19 AC104479.3 Pig clone 236/259 (91%) 
PND28v0_20 BP463666 Pig uterus clone: similarity to human 40S 468/491 (95%) 
PND28v0_24 AJ604634 Pig clone: similarity to human 40s 308/317 (97%) 
PND28v0_56 AJ663726 Pig clone: similarity to human COL1A2 188/195 (96%) 
PND28v0_81 AJ682260  POLR2B 328/331 (99%) 
PND28v0_82 BP463666 Pig uterus clone: similarity to human 40S 492/501 (98%) 
 
4.4 Quantitative Real-Time PCR 
Gene expression profiles during postnatal uterine development were generated 
for three clones chosen for analysis based on differential expression as determined by 
DIG-labeling.  The function of two clones (PND 0 vs. PND 28 #47 and PND 28 vs. PDN0 
#7) are currently unknown, while SPARCL1 has been indicated in determination of 
cellular adhesion [Nomura et al., 1988].  Abundance of these genes were determined 
using qRT-PCR. 
Primers were designed (Table 4.5) and concentrations were optimized (Figure 
4.9) so that a 10-fold dilution resulted in a difference of 3 cycle thresholds.  A melting 
curve analysis (dissociation curve) was performed for transcripts (Figure 4.10) to 
determine the optimal temperature for fluorescent data acquisition.  As seen in the 
figure, nonspecific amplification, including primer-dimers, was indicated by the initial 
fluorescent peak with a characteristic lower TM.  In this example, the specific products 
were shown with a TM around 92
oC and nonspecific products with a TM around 86
oC.  
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The optimal temperature to acquire fluorescence data was after nonspecific dissociation 
and before product dissociation.  In Figure 4.10, the optimal data acquisition was around  
88oC.  Data acquisition for the targets was 76oC for PND 0 vs. PND 28 #45 and #47 and 
72oC for PND 28 vs. PND 0 #7 (Table 4.5) 
Table 4.5.  Quantitative RT-PCR primer list for targets SPARCL1, Clone 





SPARCL1 Forward 5’-TCC TTC AGG GTG ATG TGC TTA TCC-3’ Reverse 5’-GCA GTT CAG TGA GCT TGA CCA ACA-3’ 76 
PND0_47 Forward 5’-TCA TTC ACC CTC ATC GTG TCT CCA-3’ Reverse 5’-AAG AAA CCA CCT CCC ACC TGC TTA-3’ 76 
PND28_7 Forward 5’-GGG TTG CCA TCA CAA ATC ATC GCT A-3’  Reverse 5’-CCC AGA CAC ATC CAT GTT CAT GCA AAC-3’ 72 
 
 
Figure 4.9.  Sample amplification plot from primer optimization for SYBR 
green assay.  Wells B1 and B2: 50 ng total RNA.  Wells B3 and B4:  5 ng 
total RNA.  Well B5:  No Template Control (NTC). 
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Figure 4.10.  Melting curve analysis of primers for qRT-PCR.  This 
melting curve analysis indicates that primer-dimers form in the no 
template control (NTC) samples and had an approximate TM of 86oC, as 
indicated by the single yellow peak.  Reactions with template amplify 
target cDNA, resulting in a higher TM around 92oC.  Target amplicons are 
indicated by the green, blue, and red peaks, which were shifted to the 
right of the NTC.  Appropriate data acquisition was at the temperature 
greater the NTC primer-dimer TM, yet less than the TM of the amplicon.  




Figure 4.11.  Amplification plot of SPARCL1 (PND 0 vs. PND 28 #45) qRT-
PCR using SYBR green.  Note that the threshold was set at the geometric 




Figure 4.12.  Quantitative RT-PCR of SPARCL1 (PND 0 vs. PND 28 #45) 
transcripts in postnatal uterine tissue.  Panel A) Fold difference in mRNA 
expression of SPARCL1 in postnatal pig uteri.  There was a significant 
increase in expression by PND 14, with significant decrease by PND 28 
through 56 (P ≤ 0.05), indicating a possible role of SPARCL1 during the 
proliferative stage of development.  Panel B) Efficiency of qRT-PCR 
based on the difference in slope of target (-3.565) and 18S (-4.0325) 
expression in 20, 2, and 0.2 ng total RNA.  Difference in slopes was 
0.4675. 
 68
Fold differences in transcript abundance were based on normalization with 18S 
ribosomal RNA (Table 4.6).  Expression of SPARCL1 mRNA significantly increased (P ≤ 
0.05) in expression at PND 0 and 14, with significant decrease by PND 28 through 56.  
The amplification plot (Figure 4.11) was evaluated to determine linear amplification of 
target gene as indicated by a sigmoidal curve.  Fold changes were determined by the  
2-∆∆Ct method (Figure 4.12a).  Postnatal Day 42 was set as the normalizer since it had 
the least abundant transcripts.  When compared to PND 42, PND 0 had 3.5-fold greater 
SPARCL1 transcripts, then expression increased at PND 14 to 5.89-fold, followed with a 
rapid decline in expression by PND 28 that continued until PND 56. 
Clone PND 0 vs. PND 28 #47 (accession BP169911) quantitation was not 
significantly different (P ≤ 1.0) during development.  Amplification of transcripts was 
determined by the amplification plot (Figures 4.13) and fold differences calculated 
(Figure 4.14a).  The normalizer was PND 28 as it had the least abundant transcripts and 
expression started at moderate levels, then increased to 2.3-fold at PND 14, before 
declining again at PND 28.  There was slight difference in gene expression between 
PND 0 and 28 as determined by differential screening. 
Transcripts for clone PND 28 vs. PND 0 #7 (accession CK458228) were low at 
birth (PND 0), significantly increased (P ≤ 0.05) by PND 14, then declined to initial levels.  
Fold differences were determined by setting PND 42 as the normalizer.  When 
compared to the normalizer, expression of the clone was similar at PND 0, then 
increased 2.22-fold at PND 14, before slowly declining to normalized expression at PND 
28 (Figure 4.15a).  
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Figure 4.13.  Amplifcation plot of PND 0 vs. PND 28 #47 qRT-PCR using 





Figure 4.14.  Quantitative RT-PCR of clone PND 0 vs. PND 28 #47 
transcripts in postnatal uterine tissue.  Panel A) Fold difference in mRNA 
expression of clone PND 0 vs. PND 28 #47 (accession BP169911) in 
postnatal pig uteri.  There was no significant difference in mRNA 
expression during development, but there was a slight increase at PND 
14.  Panel B) Efficiency of qRT-PCR based on the difference in slope of 
target (-2.63) and 18S (-4.0325) expression in 20, 2, and 0.2 ng total 




Figure 4.15.  Quantitative RT-PCR of clone PND 28 vs. PND 0 #7 
transcripts in postnatal uterine tissue.  Panel A) Fold difference in mRNA 
expression of clone PND 28 vs. PND 0 #7 (accession CK458228) in 
postnatal pig uteri.  Expression was low at birth (PND 0), significantly 
increases by PND 14 to 2-fold, then declines to initial levels.  The role of 
this clone us presently unknown, nevertheless it was more active during 
the proliferative stage of development.  Panel B) Efficiency of qRT-PCR 
based on the difference in slope of target (-3.2838) and 18S (-4.0325) 
expression in 20, 2, and 0.2 ng total RNA.  Difference in slopes was 
0.7847. 
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Table 4.6.  Quantitative RT-PCR analysis of gene expression for 
SPARCL1, clone PND 0 vs. PND 28 #47, and clone PND 28 vs. PND 0 
#7 in neonatal pig uteri during early postnatal growth. 
  Target 18S    
Target PND Average CT
* Average CT
* ∆CT† ∆∆CT‡ 2-∆∆CT § 
SPARCL1 0 17.27 ± 0.45 10.32 ± 0.09 6.94 ± 0.25 bc 1.817 3.5247 
 14 16.65 ± 0.42 10.45 ± 0.29 6.20 ± 0.09 c 2.56 5.8971
  
 28 18.12 ± 1.17 10.26 ± 0.06 7.86 ± 0.79 ab 0.902 1.8693 
 42 19.39 ± 1.01 10.63 ± 0.25 8.76 ± 0.54 a 0 1
  
 56 18.67 ± 1.00 10.42 ± 0.32 8.25 ± 0.48 a 0.511 1.4253 
PND0  0 15.67 ± 0.68 10.32 ± 0.09 5.35 ± 0.42 0.645 1.5637 
#47 14 15.19 ± 0.42 10.45 ± 0.29 4.75 ± 0.09 1.25 2.3784 
 28 16.25 ± 1.43 10.26 ± 0.06 5.99 ± 0.97 0 1 
 42 16.15 ± 0.90 10.63 ± 0.25 5.53 ± 0.45 0.471 1.3863 
 56 16.01 ± 0.54 10.42 ± 0.32 5.59 ± 0.15 0.403 1.3222 
PND28 0 20.04 ± 0.45 10.32 ± 0.09 9.72 ± 0.25 a 0.033 1.0232 
#7 14 19.05 ± 0.25 10.45 ± 0.29 8.60 ± 0.03 b 1.155 2.2268 
 28 19.90 ± 0.53 10.26 ± 0.06 9.64 ± 0.33 a 0.110 1.0796 
 42 20.13 ± 0.46 10.63 ± 0.25 9.50 ± 0.14 a 0.250 1.1897 
 56 20.17 ± 0.90 10.42 ± 0.32 9.75 ± 0.41 a 0 1 
 
* Cycle Threshold (CT) reflects the cycle number that target or 18S amplicon 
fluorescence crossed the geometric phase of the amplification curve.  
† Normalized CT Values (∆CT) indicates the mean target transcript CT less the 18S CT.  
Allows for the normalization of target CT in relation to endogenous 18S ribosomal RNA 
CT.  
‡ Calibrated Value (∆∆CT). The PND value in which had the greatest ∆CT (or least 
abundant transcript) for each target was set as the calibrator.  Normalized ∆CT values 
were subtracted from the calibrator.  
§ Fold Difference (2-∆∆Ct) was determined by each calibrated value.  
a-c Values with different superscript letters indicate a significant difference (P ≤ 0.05) 
between samples, while values with same superscript letters indicate no significant 
difference.  Statisical analysis was carried out using least squared means (LSM) from 
PROC MIXED of Statistical Analysis Systems (SAS). 
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Chapter 5:  DISCUSSION 
 
The onset of uterine gland morphogenesis is a postnatal event in pigs [Hadek 
and Getty, 1959; Bal and Getty, 1970; Spencer et al., 1993a], sheep [Wiley et al., 1986; 
Bartol et al., 1988a; 1988b], and rodents [Branham et al., 1985].  In pigs, the time from 
birth until PND 14 involves a general increase in uterine size, as evident by increased 
uterine weight and thickness [Hadek and Getty, 1959; Tarleton et al., 1999].   
Existing research clearly indicates the necessity for uterine glands to sustain 
normal uterine function.  These highly branched and coiled glands synthesize and 
secrete or transport substances collectively known as histotroph.  Proteins of histotroph 
provide pre-attachment nourishment and growth factors critical to conceptus survival.  
Animals in which uterine gland function is postnatally inhibited, such as the ovine UGKO 
and porcine estrogen-induced uterine disruption, the ability of the adult uterus to 
maintain normal pregnancy is compromised.  The significance of glands for uterine 
function is known; however, the mechanisms that regulate uterine morphogenesis, 
proliferation, and function are not as well understood. 
Characterization of specific gene expression during postnatal uterine 
adenogenesis in the pig offers beneficial information concerning significant 
developmental processes critical to peri-implantation conceptus survival.  This 
knowledge may serve as the basis to enhance reproductive development and uterine 
function by positively influencing conceptus survival and development. 
The use of suppression subtractive hybridization (SSH), which is based on 
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suppression PCR [Diatchenko et al., 1996], allowed for comparison of gene expression 
profiles between various stages of development.  With SSH, target cDNA fragments 
(differentially expressed) are selectively amplified while nontarget cDNA amplification is 
suppressed.  Advantages to this technique include the ability to begin SSH with small 
amounts of starting material (2 µg poly A+ RNA).  Both high and low abundance 
sequences are equalized during normalization and the method can be complete in just a 
few days.  There are also disadvantages to SSH.  First, the average cDNA size is small 
(0.1 to 2 kb) due to blunt-ended Rsa I restriction enzyme digestion.  However, the cDNA 
sizes are adequate for BLAST analysis.  Furthermore, differential screening steps are 
necessary to minimize the background and eliminate possible false-positives.  The 
present work utilized SSH to create unique cDNA libraries respective to postnatal 
development at 3 stages:  Day 0 when only shallow depressions can be observed, Day 
28 when branching morphogenesis begins, and Day 56 when glands are well 
established.   
When PND 0 was compared with PND 28, many genes identified in the forward 
subtraction, those greater at Day 0 versus Day 28, encode products involved in 
transcription or translation, including elongation factor 1 alpha 1 (EF1a1), poly(A) binding 
protein, cytoplasmic 1 (PABPC1), and polymerase (RNA) II (DNA directed) polypeptide 
C (POLR2C / RPB3).   
In addition to its role during translation, EF1a1 has been suggested to be 
involved with inhibition of apoptosis [Talapatra et al., 2002] and shows high tumor-
specific expression, relative to normal tissue [Lee, 2003].  Poly(A) binding protein, 
cytoplasmic 1 (PABPC1) is involved in the initiation of translation and mRNA turnover 
[Kozlov et al., 2001].  It is found in both the cytosol and nucleus [Grange et al., 1987] of 
eukaryotes and associated with the poly(A) tail of newly synthesized mRNA [Schwartz 
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and Darnell, 1976].  It acts as a scaffolding protein and recruits additional translation 
factors for mRNA translation [Kozlov et al., 2001].  The RNA polymerase polypeptide 
POLR2C, also known as RPB3, is most commonly known regarding its structural 
function in the polymerase II subassembly and is involved in the transcription of protein 
coding genes [Song et al., 1994]. 
The other gene of interest was secreted protein, acidic, cysteine-rich-like 1 
(SPARCL1), which influences several cellular activities and is a member of the SPARC 
protein family.  SPARC proteins are classified as matricellular proteins that function to 
bind to matrix proteins, cell surface receptors, cytokines, and proteases that interact with 
cells to regulate cell shape via “anti-adhesive” effects which ultimately leads to cell 
rounding and partial detachment from a substratum [Sage and Bornstein, 1991].  
SPARC has been referred to as 1) osteonectin, a major non-collagenous constituent of 
human and bovine bone [Termine et al., 1981], 2) a BM40, a component of the 
basement membrane [Dziadek et al., 1986], and 3) SPARC (Secreted Protein Acidic and 
Rich in Cysteine) from mouse parietal endoderm [Mason et al., 1986].  The anti-
adhesive cell-matrix regulator glycoprotein SPARC [Johnston et al., 1990; Lane and 
Sage, 1994] has been shown to inhibit cell spreading on collagen and induce cell 
rounding in cultured endothelial cells and fibroblasts [Sage et al., 1989].  Such changes 
in cell adhesion mediated by SPARC are thought to influence a number of cellular 
activities including proliferation, migration, and differentiation [Bradshaw and Sage, 
2001].   
The SPARC protein family has a similar basic structure of acidic residue clusters, 
a follistatin-like cysteine-rich region, and a high affinity calcium binding region, termed an 
EF hand [for review see Lane and Sage, 1994].  This protein family is extracellular and 
mediates cell-matrix interactions [Sage and Bornstein, 1991].  The SPARC protein has 
domains that can function independently to bind cells and matrix components [Engel et 
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al., 1987].  Domain I is highly acidic and has a relatively low binding affinity for calcium 
[Lane and Sage, 1994].  Domain II is homologous to a repeated domain in follistatin, a 
cytokine inhibitor.  Domains II an IV (termed the extracellular [EC] domain) bind calcium 
to collagen IV [Maurer et al., 1995].  The member SPARCL1 has been referred to as 1) 
SC1 in mice [Johnston et al., 1990], 2) hevin from human tonsil high endothelial venule 
cells [Girard and Springer, 1996], 3) mast9 (magnet-assisted subtraction technique) in 
lung carcinoma [Schraml et al., 1994], and 4) renamed to SPARC-like 1 (SPARCL1) due 
to its high homology to SPARC-protein family members [Isler et al., 2001].  SPARCL1 
has approximately 65% conservation with the last two-thirds of SPARC [Girard and 
Springer, 1996].  Due to the homology between SPARCL1 and SPARC, it is possible 
that SPARCL1 shares some of the same features. 
In addition to regulating cell shape, SPARC regulates the activity of several 
growth factors including TGF-β1 [Francki et al., 1999] and binds to ECM proteins such 
as collagen type I [Sasaki et al., 1998] via the extracellular calcium-binding domain 
[Maurer et al., 1997].  A study in mice indicated that SPARC stimulates collagen type I 
production through a TGF-β1-dependent pathway [Francki et al., 1999].  In many 
tissues, the ECM is composed of collagens, proteoglycans, and non-collagenous 
glycoproteins that form complex structures.  SPARCL1 involvement in cell-matrix 
interactions is supported by the expression of hevin from human high endothelial venule 
(HEV) cells [Girard and Springer, 1996].  Girard and Springer [1996] showed that 
SPARCL1 (hevin) was associated with the basal, lateral, and apical surfaces of HEV 
cells and is not expressed in the underlying basement membrane.  Furthermore, purified 
SPARCL1 did not support human umbilical vein endothelial cell adhesion in vitro and 
exogenous SPARCL1 inhibited attachment and spreading of endothelial cells on 
fibronectin substrates [Girard and Springer, 1996], while inhibition of cell spreading is 
concentration dependant [Lane and Sage, 1990]. 
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The expression of SPARCL1 is variable.  It is expressed in rat embryonic and 
adult neurons in the central nervous system with the highest levels in the adult brain 
[Johnston et al., 1990].  Soderling and coworkers [1997] detected SPARCL1 in adult 
mouse lung bronchi and bronchioles, larger vessels of cardiac muscle, vessels in the 
liver, and throughout the red pulp of the spleen.  SPARCL1 was not detected in cultured 
and proliferataing endothelial cells or smooth muscle cells [Soderling et al., 1997].    Isler 
and coworkers [2001] proposed that SPARCL1 may function to mediate cell matrix 
interactions to support cellular differentiation, and not promoting proliferation.  Claeskens 
and coworkers [2000] showed in HeLa3S cancer cells that overexpression of SPARCL1 
reduced cell proliferation.  SPARCL1 has been shown to be down regulated in colorectal 
[Notterman et al., 2001], lung [Isler et al.,2004] and prostate cancers [Claeskens et al., 
2000; Nelson et al., 1998].  Other work has shown up regulation of SPARCL1 in cancer 
cells including renal cell carcinoma [Gerritsen et al., 2002], pancreatic adenocarcinoma 
[Sasaki et al., 2004], and on the luminal duct epithelial cells of human endometrial 
adenocarcinoma [Brekken et al., 2004].  Berekken and coworkers [2004] suggested that 
these differences might be resolved by time-course studies of tumor development and 
evaluating the type and degree of adhesion.   
In the reverse comparison when PND 28 was the tester and PND 0 the driver, 
gene products that had greater expression at Day 28 versus Day 0 were identified.  Two 
different types of collagen were identified, pro alpha 2 (I) collagen (COL1A2) and type III 
procollagen (COL3A1), transcripts with strong similarity to human 40S ribosomal protein 
S6, and Polymerase (RNA) II (DNA directed) polypeptide (POLR2B / RPB2).  
Procollagen types I-III are fibrilar and the propeptide segments must be extracellularly 
cleaved before the mature proteins can undergo fiber formation [Bornstein, 1980].  Type 
III often colocalizes with type I at a 1:5 ratio in the rat uterus [Hurst et al., 1994].  Type I 
collagen is the most common structural collagen in the human uterus [Hurst et al., 1994] 
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throughout the myometrium.  In the rat, is has been suggested that progesterone 
regulates adult uterine tissue remodeling [Shynlova et al., 2004] as evident after the 
administration of exogenous progesterone inhibited collagenase expression [Koob and 
Jeffrey, 1974] and increased total amount of collagen.  Expression of these two 
procollagens in the neonatal pig uterus is likely to be determined by the early expression 
of SPARCL1 and presence of growth factors.  
Identification of a clone with similarity to human 40S may indicate a gene that 
contributes to the control of cell growth and proliferation.  Human 40S controls cell 
growth and proliferation through the selective translation of particular classes of mRNA 
[O'Connor et al., 2003].  Increased expression of this factor at PND 0 when compared to 
PND 28 makes since being that at birth, the neonate uterus is actively initiating 
increased cellular activity including the proliferation and migration of GE from the LE at 
PND 0. 
A second RNA Polymerase II subunit was identified in the reverse subtraction.  In 
this comparison, POLR2B was isolated.  It is otherwise known as RBP2 and is the 
second largest RNA binding protein of the Polymerase II subassembly.  Similar to 
POLR2C, POLR2B acts as a scaffolding protein to recruit additional translation factors 
for mRNA translation [Kozlov et al, 2001]. 
The PND 28 versus PND 56 comparison resulted in fewer differentially 
expressed genes and only one novel gene was detected.  This is not too surprising since 
morphologically there is a continuation of branching morphogenesis, instead of dramatic 
remodeling events that are associated with the initiation of gland budding and 
proliferation.  Therefore, qRT-PCR was not performed for either forward or reverse 
subtraction.  
Quantitative RT-PCR of SPARCL1 and clone PND 28 vs. PND 0 #7  both 
showed a significant increase during the proliferative stage of uterine development.  
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Clone PND 28 vs. PND 0 #7 did not show a difference in expression between PND 0 
and 28, as anticipated.  A contrast between differential screening analysis and qRT-PCR 
results is possible due to objective interpretation of spot intensity on each DIG-labeled 
membrane.  Although the two PNDs in comparison were different for clone PND 28 vs. 
PND 0 #7, the qRT-PCR results helped further identify the time period that may be 
crucial to successful postnatal uterine development in the pig.  Clone PND 0 vs. PND 28 
#47  did not show significant difference in fold expression at any PND evaluated, but did 
indicate a trend for greater expression at PND 14, similar to SPARCL1 and  clone PND 
28 vs. PND 0 #7. 
Little is known about the function of SPARCL1 in the neonatal porcine uterus 
other than it has high expression at PND 0 and 14 when compared to PND 28, 42, and 
56.  High expression of SPARCL1 at PND 0 and 14 is at the same time when uterine 
glands are undergoing morphological changes and cells are proliferating and migrating 
during budding and tubulogenesis.  These events suggest an association with GE 
migration through the uterine stroma.  This study adds further support to the contention 
that anti-adhesive molecules may contribute to the morphogenesis of the neonatal pig 
uterus. 
Interpretation for the qRT-PCR profiles of the other two clones is difficult since 
there is no known function as of yet.  Further analysis such as tissue localization for the 
specific products should aid in better identification for the function of  these gene 
expression profiles in the neonatal pig uterus. 
Overall, results of SSH showed that the period of postnatal growth from Day 0 to 
28 has much more different activity than from Day 28 to 56.  These data agree with the 
morphological events that occur during postnatal growth of the pig uterus.  From day 0 to 
28, glands emerge from simple depressions at the LE, penetrate the underlying stroma 
to form tubes, then actively undergo lateral side branching.  After PND 28, there is no 
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initiation of new morphological events as branching morphogenesis continues through 
PND 56.   
In summary, the current work identified a time period critical for the establishment 
and successful development of neonatal porcine uterine glands.  Expression levels for 
all three transcripts evaluated showed a similar pattern of high levels at PND 0 and 14, 
then declining to normalized values at PND 28, 42, and 56.  Therefore, we conclude that 
the factors responsible for the initiation of uterine glands are activated at birth, when only 
buds are present, through PND 14, when glands are forming tubes.  These high levels of 
different transcripts may serve to regulate glandular epithelium migration through the 
stroma during glandular budding and tubulogenesis.  Meanwhile, increased expression 
of transcripts are most likely establishing an appropriate microenvironement for the 
initiation of branching morphogenesis at PND 28.  Clearly, further analysis of SPARCL1 
in the pig is necessary to determine if this molecule can interact with other ECM 
molecules to promote and enhance uterine gland development.  Identifying mRNA 
expression in late fetal development through early postnatal development would help 
determine the onset and expression profile of SPARCL1 in the pig uterus.  Additional 
studies such as in situ hybridization and protein expression would further aid in 
clarification of the role SPARCL1 in the neonatal pig uterus.  Furthermore, it would be 
interesting to examine the expression of growth factors and collagen in the uterus 
following the treatment of neonate gilts over a timecourse  with exogenous SPARCL1 to 
see whether uterine gland development is enhanced.  If this is true, it would be possible 
to increase uterine capacity and the number of uterine glands, so that GE can secrete 
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Scope and Method of Study:  Specific changes in gene expression involved in the 
completion of uterine gland development during the first 56 days of postnatal growth in 
the pig have not been well described or understood.  The present work utilized 
suppression subtractive hybridization (SSH) to create unique cDNA libraries respective 
to postnatal development at 3 stages:  Day 0 when only shallow depressions can be 
observed, Day 28 when branching morphogenesis begins, and Day 56 when glands are 
well established.   
Findings and Conclusions:  A total of 288 SSH products were screened in two forward 
and reverse reactions.  Of these, 67 were identified to be differentially expressed 
through dot-blot hybridization assays using DIG-labeled probes.  Only 34 were subjected 
to sequencing and BLAST analysis.  Sequence analysis  revealed 25/34 quality readings 
and 16/25 matched known sequences, while 7/25 returned identity to uncharacterized 
clones, and 2/25 had no significant match to any known sequences.  Comparison of 
PND 0 with PND 28 showed genes in the forward subtraction represent those involved in 
transcription or translation, including elongation factor 1 alpha 1  (EF1a1), poly(A) 
binding protein, cytoplasmic 1 (PABPC1), and polymerase (RNA) II (DNA directed) 
polypeptide C (POLR2C / RPB3).  One other gene of interest found was secreted 
protein, acidic, cysteine-rich-like 1 (SPARCL1) which influences several cellular activities 
including proliferation, migration, and differentiation.  Gene products that had greater 
expression at Day 28 than Day 0 included type II procollagen (COL1A2) and type III 
procollagen (COL3A1) which are important in tissue structure.  Also identified in the 
reverse subtraction was a clone with strong similarity to human 40S, which may indicate 
a gene that contributes to the control of cell growth and proliferation.  The PND 28 
versus PND 56 comparison resulted in fewer differentially expressed genes and only 
one novel gene was detected.  Quantitative real-time PCR (qRT-PCT) assays were 
performed for SPARCL1 and two uncharacterized clones.  Expression levels for all three 
transcripts evaluated showed a similar pattern of high levels at PND 0 and 14, then 
declining to normalized values at PND 28, 42, and 56.  Therefore, we conclude that the 
factors responsible for the initiation of uterine glands are activated at birth, when only 
buds are present, through PND 14, when glands are forming tubes.  These high levels of 
different transcripts may serve to regulate glandular epithelium migration through the 
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